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Abstract 
Medicago truncatula is a model for investigating legume genetics and the evolution 
of legume-rhizobia symbiosis. Over the past two decades, two large gene families in M. 
truncatula, the nucleotide-binding site leucine-rich repeat (NBS-LRR) family and the 
nodule-specific, cysteine-rich (NCR) gene family, have received considerable attention 
due to their involvement in disease resistance and nodulation, large family size, and high 
nucleotide and copy number diversity. While NBS-LRRs have been found in all plant 
species and therefore relatively well characterized at the sequence level, members of the 
cysteine-rich protein (CRP) families, including NCRs, have generally been overlooked by 
popular similarity search tools and gene prediction techniques due to their (a) small size, 
(b) high sequence divergence among family members and (c) limited availability of 
expression evidence. In this thesis, I first developed a homology-based gene prediction 
program (Small Peptide Alignment Detection Algorithm, i.e., SPADA) to accurately 
predict small peptides including CRPs at the genome level. Given a high-quality profile 
alignment, SPADA identifies and annotates nearly all family members in tested genomes 
with better performance than all general-purpose gene prediction programs surveyed. 
Numerous mis-annotations in the current Arabidopsis and Medicago genome databases 
were found by SPADA, most supported by RNA-Seq data. As a homology-based gene 
prediction tool, SPADA works well on other classes of small secreted peptides in plants 
(e.g., self-incompatibility protein homologues) as well as non-secreted peptides outside 
the plant kingdom. 
I then comprehensively annotated the NBS-LRR and NCR gene families in the 
Medicago reference genome (version 4.0), and set out to characterize natural variation of 
these genes in diverse M. truncatula accessions. Previous studies using whole-genome 
sequence data to identify sequence polymorphisms (SNPs and short Insertion / Deletions) 
relied on mapping short reads to a single reference genome. However, limitations of read-
mapping approaches have hindered variant detection, especially characterization of 
repeat-rich and highly divergent regions. As a result, studies of these large gene families 
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are also hindered due to high sequence similarity among family members along with high 
divergence among accessions. In this work I constructed high-quality de novo assemblies 
for 15 M. truncatula accessions. This allowed me to detect novel genetic variation that 
would not have been found by mapping reads to a single reference. This analysis led to a 
within-species diversity estimate 70% higher than previous mapping-based resequencing 
efforts, even using a smaller sample size. These results clearly demonstrate that de novo 
assembly-based comparison is both more accurate and precise than mapping-based 
variant calling in exploring variation in repetitive and highly divergent regions.  
For the first time in plants, my results enable systematically identification and 
characterization of different types of structural variants (SVs) using a synteny-based 
approach. This analysis suggests that, depending on the divergence from the reference 
accession, 7% to 21% of the entire genome is involved in large structural changes, 
affecting 10% to 28% of all gene models. The results identify 64 Mbp of unique sequence 
segments absent in the reference, including 30 Mbp shared by at least 2 accessions and 34 
Mbp of accessions-specific sequences, thus expanding the Medicago reference space 
(389-Mbp) by 16%.  
Evidence-based annotation of the 15 de novo assemblies revealed that more than half 
of reference gene models were structurally diverse (lower than 60% sequence similarity) 
in at least one other accession. Not surprisingly, the NBS-LRR gene family harbors by far 
the highest level of nucleotide diversity, large effect single nucleotide changes, mean 
pairwise protein distance and copy number variation (levels comparable with 
transposable elements), consistent with the rapidly-evolving dynamics of disease 
resistance phenotypes. Characterization of deletion and tandem duplication events in the 
NBS-LRR and NCR gene families suggests accession-specific subfamily expansion / 
contraction patterns. This work illustrates the value of multiple de novo assemblies and 
the strength of comparative genomics in exploring and characterizing novel genetic 
variation within a population, and provides insights in understanding the impact of SVs 
on genome architecture and large gene families underlying important traits. 
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Chapter 1. Detecting Small Plant Peptides Using SPADA 
Small peptides encoded as one- or two-exon genes in plants have recently been 
shown to affect multiple aspects of plant development, reproduction and defense 
responses. However, popular similarity search tools and gene prediction techniques 
generally fail to identify most members belonging to this class of genes. This is largely 
due to the high sequence divergence among family members and the limited availability 
of experimentally verified small peptides to use as training sets for homology search and 
ab initio prediction. Consequently, there is an urgent need for both experimental and 
computational studies in order to further advance the accurate prediction of small 
peptides. 
I present here a homology-based gene prediction program to accurately predict small 
peptides at the genome level. Given a high-quality profile alignment, SPADA identifies 
and annotates nearly all family members in tested genomes with better performance than 
all general-purpose gene prediction programs surveyed. Numerous mis-annotations were 
found in the current Arabidopsis thaliana and Medicago truncatula genome databases 
using SPADA, most of which have RNA-Seq expression support. I also show that 
SPADA works well on other classes of small secreted peptides in plants (e.g., self-
incompatibility protein homologues) as well as non-secreted peptides outside the plant 
kingdom (e.g., the alpha-amanitin toxin gene family in the mushroom, Amanita 
bisporigera). 
SPADA is a free software tool that accurately identifies and predicts the gene 
structure for short peptides with one or two exons. SPADA is able to incorporate 
information from profile alignments into the model prediction process and makes use of 
it to score different candidate models. SPADA achieves high sensitivity and specificity in 
predicting small plant peptides such as the cysteine-rich peptide families. A systematic 
application of SPADA to other classes of small peptides by research communities will 
greatly improve the genome annotation of different protein families in public genome 
databases.!  
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Introduction 
A major challenge in translating new genome sequences into useful community 
resources is the accurate annotation of genes and other functionally relevant features 
(Stein 2001). While there have been clear improvements in gene prediction algorithms 
(Yao et al. 2005), accurate prediction of small one and two-exon genes remains 
stubbornly problematic (Basrai, Hieter, and Boeke 1997). False-positive signals arising 
from the poor specificity of promoter motifs and other commonly-used signals employed 
by general purpose gene-finding algorithms are widespread (Lease and Walker 2006; 
Hanada et al. 2007; Yang et al. 2011; B. Pan et al. 2013). To address the flood of false-
positive signals for small genes, many annotators filter out small-gene predictions lacking 
direct experimental expression evidence, resulting in a major problem of false negatives 
(Basrai, Hieter, and Boeke 1997; Lease and Walker 2006). 
I propose here an alternative and complementary strategy for genome-wide 
annotation – a strategy that has as its strength predicting the small one- and two-exon 
genes that all-purpose gene-finding algorithms often fail to predict accurately. This 
approach focuses on finding all related paralogous genes within a target gene family and 
then using signals from the corresponding multiple sequence alignment to aid in refining 
the model predictions. I have implemented this approach in an open-source and freely 
available application called SPADA (Small Peptide Alignment Discovery Application). 
SPADA can be used directly with a user’s own protein family alignments or with a 
comprehensive set of protein family alignments from public sources such as Pfam (Punta 
et al. 2011), InterPro (Hunter et al. 2012) or PROSITE (Sigrist et al. 2013), enabling the 
exhaustive discovery of essentially all members of the input families within a given 
genome sequence. Because these public resources continue to expand and include new 
and novel protein families, SPADA’s ability to comprehensively identify arbitrarily large 
families of small peptides in genomes will steadily grow. 
Here I describe the conceptual basis of SPADA and go onto test its performance with 
selected families of notoriously difficult genes to annotate properly – specifically, plant 
Cysteine-Rich Peptides (CRPs) in two model plant species (Arabidopsis thaliana and 
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Medicago truncatula), the S-Protein homologue (SPH) family in A. thaliana, and the 
alpha-amanitin toxin gene family in the mushroom Amanita bisporigera. In the case of 
CRPs, we examine the accuracy and recall compared to published composite test/training 
sets for these species based on previous semi-manual curation and subsequent 
experimental expression validation (Silverstein et al. 2007; Nallu et al. 2013; Tesfaye et 
al. 2013). I also compare SPADA’s performance against a number of commonly used 
generic gene-prediction algorithms (Majoros, Pertea, and Salzberg 2004; Lomsadze et al. 
2005; Blanco, Parra, and Guigó 2007; Keller et al. 2011), providing evidence of 
SPADA’s advantage in identifying these challenging classes of small peptides. 
Method 
SPADA is a computational pipeline that, when provided with a multiple sequence 
alignment for a gene/protein family of interest, identifies all members of this family in a 
target genome. Technically, SPADA’s pipeline is a general homology-based gene finding 
program with specifically enhanced power to detect and annotate small peptides with one 
or two exons. Unlike general-purpose gene prediction programs such as Fgenesh 
(Salamov and Solovyev 2000), SPADA works on an entire gene family at one time - with 
the goal of finding all family members in the genome. Unlike other homology-based gene 
predictors such as Genewise (Birney, Clamp, and Durbin 2004) and Exonerate (Slater 
and Birney 2005) that map a single protein sequence to the target genome, SPADA 
performs a similarity search using a profile alignment and identifies all homologs of the 
family. In addition, SPADA provides automated access to both similarity search tools 
(e.g., BLAST (Altschul et al. 1990) and HMMER (S R Eddy 1998) and ab initio gene 
predictors (e.g., Augustus), significantly improving the annotation efficiency of multi-
member gene families. As shown in Figure 1.1, SPADA consists of four consecutive 
components: a) Pre-Processing, b) Motif Mining, c) Model Prediction and d) Model 
Evaluation & Selection.  
In SPADA, HMMER (S R Eddy 1998) is first used to identify hits in the target 
genome sequence (translated in six reading frames) as well as in the target proteome (if 
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available) using a reasonably generous E-value (10). These hits are then tiled with regard 
to their genomic coordinates and merged into overlapping clusters. Finally, one best hit in 
each cluster is picked to generate a list of candidate hits. 
The pipeline then allows the user to run one or more processes to predict gene 
structures for these potential genes. By default, SPADA runs Augustus (Keller et al. 
2011) using hit locations as clues for “CDS regions” (coding sequence). In parallel, 
SPADA runs a custom pipeline optimized for predicting the exon boundaries of genes 
containing one or two exons using GeneWise (Birney, Clamp, and Durbin 2004), 
SplicePredictor (Brendel, Xing, and Zhu 2004) and custom Perl scripts. 
In the next step, all gene structure predictions are combined to make a raw calling 
set, with each hit having one or more gene structure predictions. SPADA uses multiple 
statistics to assess the confidence of each candidate gene model, including an alignment 
score (mean pairwise score with known members in the original family-specific multiple 
sequence alignment), an HMM alignment score (sum of posterior probability scores in 
the Hmmsearch output file), the presence/absence of proper start/stop codons, as well as 
the SignalP D-score (Petersen et al. 2011) in the case of secreted peptides. 
Finally, the best candidate gene model is picked for each hit and the resulting set is 
filtered using empirical cutoffs (hmmsearch E-value of 0.001) to remove false positives. 
Pre-processing 
Building family-specific multiple sequence alignments 
The original motivation for developing this pipeline was accurately identifying and 
predicting Cysteine-Rich Peptides (CRPs) in plant genomes. For this purpose, SPADA 
comes with a complete set of manually-curated protein sequence alignments for plant 
Cysteine-Rich Peptide (CRP) families (Silverstein et al. 2007). In 2007, Silverstein et al. 
built multiple sequence alignments for most plant CRP families through iteratively 
scanning EST sequences from different plant species in TIGR’s Gene Indices (now JCVI) 
(Silverstein et al. 2007). These alignments were re-aligned here using ClustalO (Sievers 
et al. 2011) and trimmed using trimAl (Capella-Gutiérrez, Silla-Martínez, and Gabaldón 
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2009) to remove spurious sequences and poorly aligned positions. Finally, a profile 
Hidden Markov Model (HMM) was built for each CRP family using ‘hmmbuild’ in the 
HMMER package (Sean R. Eddy 2011). 
As a general homology-based gene finding program, SPADA has been designed to 
work with any set of protein families. Users can start with a list of amino acid sequence 
alignments of their own interest, run the script “build_profile.pl” to generate custom 
HMM profiles, and initiate the pipeline using the new HMM(s). With this in mind, I have 
tested SPADA’s performance on an additional protein family as a proof of concept (see 
Results section) and assessed its applicability to secreted protein families other than 
CRPs. 
Processing genome sequence and annotation 
In SPADA, genome FASTA sequences are translated in all six reading frames to 
amino acid sequences and then Open Reading Frames (ORFs) are extracted by breaking 
up these long amino acid sequences using stop codons. Here an ORF is defined as a 
segment of amino acid sequence with at least 15 residues and uninterrupted by stop 
codons. Extracting ORFs from the original translated genomic sequence reduces the 
target database size for the subsequent motif mining step and improves sensitivity. Using 
ORFs also ensures that no protein-coding exon spans stop codons in the middle of a 
sequence and that each exon will have a reasonable length. In theory, all protein-coding 
exons should locate within these ORFs, which will be discovered in the next motif-
mining step. However, the exact exon boundaries are still unclear at this point of the 
search procedure. 
If a gene annotation file in General Feature Format version 3.0 (GFF3) is available, 
SPADA can also read and process it, extracting the amino acid sequences of existing 
annotations and passing them onto the next motif mining step. In doing so, exon 
boundaries can be better refined, further improving the accuracy in the model prediction 
step. 
Hard-masking of genome sequences is recommended (replacing repetitive sequences 
with ‘N’s) before running the pipeline. Some plant species have very large genomes with 
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highly repetitive content (e.g., Maize (Schnable et al. 2009)). By hard-masking the 
genome sequence, the target database size in the motif-mining step is effectively reduced, 
significantly improving the search sensitivity of the entire pipeline. However, if many 
family members locate in repeat-rich genomic regions (such as the fungi effector families 
(Rep and Kistler 2010)), the unmasked genome version should be used. 
Motif mining 
In SPADA, profile HMMs are used to search against translated genomic sequences 
(and known protein sequences, if available) using hmmsearch, a component of the 
HMMER package (v3.0) (Sean R. Eddy 2011). This program finds significant hits 
against a protein sequence database using one or more profiles as inputs. The output of 
the scan is a list of genomic intervals with significant sequence similarity to query 
profiles and amino acid sequences translated from these intervals. For single-exon genes, 
a contiguous stretch of amino acid sequence in the target databases will be discovered, 
roughly corresponding to the exon in the original genomic sequence. For genes 
containing two or more exons, partial amino acid sequence hits corresponding to different 
exons will be separated by introns (if they share a reading frame) or distributed in 
different target sequences (if in different reading frames). SPADA collects all these full 
and partial hits in translated protein sequences, recovers their original genomic 
coordinates, filters out low-significance hits (E-value higher than 0.1), selects the most 
significant hit for each genomic interval since multiple input profiles may hit the same 
region, and merges nearby partial hits. During this merging step, SPADA requires that 
each neighboring partial hit should hit a different segment (either upstream or 
downstream) in the input profile HMM. The merged genomic intervals (called “extended 
hits”) roughly correspond to the multiple exons in the underlying gene model - although 
the exact intron-exon boundaries and start/stop codon locations are yet to be refined at 
this stage of the procedure. 
In parallel, SPADA searches against existing protein sequences (generated using the 
GFF3 annotation file), yielding a separate list of hits to the input profiles. These hits are 
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also treated as partial hits, i.e., mapped to their original genomic coordinates and then 
used to build “extended hits”. This “hmmsearch against proteome” step is considered 
complementary to the abovementioned “hmmsearch against translated genome” step, 
since it improves prediction sensitivity by capturing otherwise non-significant partial hits 
in the translated genome search. 
Model prediction 
At this point, SPADA has generated a list of “extended hits” approximately 
corresponding to actual exon boundaries. For each extended hit the surrounding genomic 
sequence is extracted. By default, 2500 bp upstream from the hits are extracted, since the 
first exon (containing the signal peptide) is usually separated from the second exon (with 
the mature peptide) by an intron up to 1500 bp, as determined by manual curation and 
understanding of plant genomes. At the other end, 1500 bp downstream from the hit 
boundaries are extracted, since the correct stop codon can typically be found within 1000 
bp downstream of the HMM hit. SPADA next runs one or more components (selected by 
the user) in parallel to determine gene structure in this region. A total of five prediction 
components are currently supported by the pipeline: Augustus (Keller et al. 2011), 
GeneWise (Birney, Clamp, and Durbin 2004), GlimmerHMM (Majoros, Pertea, and 
Salzberg 2004), GeneMark (Lomsadze et al. 2005) and GeneID (Blanco, Parra, and 
Guigó 2007). By default SPADA only runs two of these components (Augustus and 
GeneWise) since performance evaluation on a group of common plant peptides suggests 
that running all five of them does not offer a significant extra gain compare to running 
just two of them (see Results & Discussion).  
The first component, which I denote “Augustus_evidence”, runs Augustus (Keller et 
al. 2011) in its “evidence mode”. The genomic sequence is used as input along with a 
“hint file” providing the program instructions for which part(s) of the input sequence are 
known to be part(s) of the coding sequence. In other words, location information of 
extended hits is incorporated in the prediction process. Augustus will then try to complete 
the gene model by looking for start/stop codons and canonical donor-acceptor splice sites 
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around the hits while preserving the open reading frame. The improvement in prediction 
accuracy and specificity by running Augustus in the “evidence mode” (as compared to 
the “Augustus de novo mode”) is significant and will be discussed in Results & 
Discussion. 
In parallel, SPADA runs a custom pipeline specifically designed to identify and 
predict genes with one or two exon(s) and with a leading signal peptide. This component, 
which we denote “Genewise+SplicePredictor”, first runs GeneWise to align the extended 
hit sequence (translated to amino acid sequence) to genomic sequence and identifies 
compatible splice sites that preserve the hit ORFs. If GeneWise fails due to non-canonical 
splice sites, SPADA then runs SplicePredictor (Brendel, Xing, and Zhu 2004) to find all 
possible donor/acceptor splice sites and extracts compatible ones, extending the ORFs to 
the nearest start codon and stop codon. In practice, this “Genewise+SplicePredictor” 
approach works well as a complement to the “Augustus_evidence” approach (see Results 
and Discussion). 
At this stage in the pipeline, SPADA reports all compatible gene models predicted 
by the two components. These candidate models are then passed on to the next step for 
evaluation in order to generate a best calling set. 
Model evaluation & selection 
For each extended hit, SPADA then evaluates the underlying candidate models using 
a number of measures and picks the most “confident” model for output. These evaluation 
statistics include the presence of start/stop codons at the beginning/end of the model, the 
presence of inframe stop codons, the SignalP score (Petersen et al. 2011) in the case of a 
secreted gene family, and in particular, the Multiple Sequence Alignment (MSA) score 
and the “Hmmsearch Probability” (HmmProb) score, as described below. 
In theory, the correct gene model should encode an amino acid sequence that aligns 
to the original family-specific protein alignments better than any other candidate models. 
To calculate the MSA score, SPADA aligns the amino acid sequence of the candidate 
model to the profile alignment using ClustalO “profile-to-profile” mode (Sievers et al. 
  9 
2011). SPADA then scores all pairwise alignments using BLOSUM80 scoring matrix 
(Henikoff and Henikoff 1992) and calculates a mean alignment score. The BLOSUM80 
matrix is used instead of BLOSUM62 because the sequences that are being aligned tend 
to be fairly similar to each other, and a matrix with more conserved target frequencies 
such as BLOSUM80 should be more reasonable. Ideally, the candidate model with the 
highest MSA score should be the most probable model. 
Nevertheless, the MSA score is not sufficient to pick the best model, since candidate 
models are sometimes too close to each other in sequence and the MSA scores may not 
vary appreciably among model alternatives. Therefore SPADA also calculates an 
“Hmmsearch Probability” Score for each candidate model. In theory, if hmmsearch is run 
using the original family HMM against all candidate models, the most significant hit in 
the output should then be the best model. In practice, the probability score in the 
hmmsearch output serves as a better predictor than the E-value itself, especially when a 
model contains more than one hit domain. The MSA score and the HmmProb score are 
used to evaluate each candidate model. SPADA then picks the best candidate model that 
meets the following criteria: (1) it has a SignalP D-score of no less than 0.4 (determined 
according to the software manual, this option could be turned off to allow prediction of 
non-secreted gene families); (2) it has proper start/stop codons and no premature stop 
codon; and (3) it has the highest (MSA score + HmmProb score). 
SPADA uses a relatively relaxed E-value cutoff in the motif mining step (e.g., 10 for 
running hmmsearch) in order to increase specificity. This also results in numerous false 
positive hits. These hits will generally not have valid candidate gene models built for 
them in the model prediction step, and thus would not make it into the ultimate output. 
However, SPADA does employ a final filtering step based on hmmsearch E-value to 
refine gene models that are retained. Performance of the pipeline under different final E-
value cutoffs (see Results and Discussion) are evaluated and the default cutoff is set to 
0.001, which may be adjusted by the user to achieve customized search purposes. For all 
gene models passing the filter, SPADA outputs the sequences in FASTA format and gene 
coordinate information in GFF format. SPADA also generates for each gene family a 
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multiple sequence alignment including all predicted models and the family-specific 
consensus sequence. If a gene annotation file has been passed to the pipeline, SPADA 
will also report the comparison results of predicted models with existing annotation (e.g., 
the number of models with exactly the same exon boundaries, models with partial 
overlap, models in different reading frames, etc.). 
Performance evaluation 
Compilation of the test set 
A test set of plant cysteine-rich peptides (CRPs) was compiled in two genomes: the 
model dicotyledon, Arabidopsis thaliana, and the model legume, Medicago truncatula. In 
previous work, Silverstein et al. (Silverstein et al. 2007) have exhaustively searched and 
curated all 516 CRP families (CRP0000 - CRP6250) in Arabidopsis. A large number of 
CRPs have also been identified and curated in an early release of the Medicago genome 
sequence (Silverstein et al. 2007). Recently, as a collaborative effort with J. Craig Venter 
Institute (JCVI), we expanded this list of CRPs in M. truncatula by manually inspecting 
and curating 136 CRP families (CRP0000 - CRP1530, focusing specifically on the 
Defensin-Like proteins or DEFLs) in M. truncatula (Nevin D. Young et al. 2011). This 
finally led to a complete list of CRP members for Arabidopsis and Medicago (742 for 
Arabidopsis and 725 for Medicago, Appendix File 1.1). 
Evidence from multiple sources was collected to validate the expression of the 
models in the compiled test set. On the one hand, extensive RNA-Seq data were 
downloaded from NCBI Sequence Read Archive (Leinonen, Sugawara, and Shumway 
2011) for both Arabidopsis and Medicago; on the other hand, I downloaded the 
AtMtDEFL microarray dateset (Nallu et al. 2013; Tesfaye et al. 2013) to seek additional 
support for expression of these gene families. The AtMtDEFL array include probe sets 
for 317 Arabidopsis DEFLs, 15 Arabidopsis DEFL-related Genes (MEGs), and 684 
Medicago DEFLs, plus additional marker genes. In total, 583 (78.6%) out of the 742 
CRPs in the Arabidopsis test set and 657 (90.6%) out of the 725 Medicago CRPs receive 
support from either RNA-Seq (FPKM >1) or microarray data (Appendix Table 1.3-1.4). 
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These carefully curated, high-quality CRP calls were then taken as our test set in 
evaluating the performance of different model prediction components in SPADA under 
different hmmsearch E-value cutoffs. 
Evaluation procedure 
A number of popular gene prediction programs were tested as SPADA model 
prediction components. In addition to the previously mentioned components, I also tested 
GeneID (v1.4.4) (Blanco, Parra, and Guigó 2007), GlimmerHMM (v3.0.1) (Majoros, 
Pertea, and Salzberg 2004), GeneMark (v3.9d) (Lomsadze et al. 2005), and Augustus 
(v2.6.1, de novo mode). The “Augustus_evidence” differs from the “Augustus_de_novo” 
component simply by the inclusion of a “hint file” (with hit location information) fed to 
the program. I evaluated the pipeline performance running these components 
(individually or in combination) based on our curated test dataset (see Results and 
Discussion), and decided to use the “Augustus_evidence” and 
“Genewise+SplicePredictor” approaches as default components in the SPADA model 
prediction step. 
Prediction performance was measured at two different levels: coding nucleotide 
sequence and exonic structure. At each level, sensitivity and specificity for each 
component were calculated. I first define the true positives (TP, number of coding 
nucleotides that are correctly predicted as coding), true negatives (TN, number of 
noncoding nucleotides that are correctly predicted as noncoding), false negatives (FN, 
number of coding nucleotides predicted as noncoding) and false negatives (FP, number of 
noncoding sequences predicted coding). At the nucleotide level, Sensitivity (Sn) was then 
calcualted as the proportion of coding nucleotides that have been correctly predicted as 
coding (Sn=TP/(TP+FN)), while Specificity (Sp) was the proportion of predicted coding 
nucleotides that are actually coding (Sp=TP/(TP+FP)) (Burset1996). At the exon level, 
Sn was the proportion of actual exons in the input sequence that are correctly predicted, 
while Sp was the proportion of all predicted exons that are correctly predicted (Burset 
and Guigó 1996). Other measures such as Correlation Coefficient (CC) and Average 
Conditional Probability (ACP) were not evaluated since they require the calculation of 
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TN nucleotides/exons, which are noncoding regions that are predicted as noncoding. 
Unlike a general gene-finding program that tries to predict all coding genes in a given 
sequence, SPADA focuses only on coding genes that are significantly similar to a given 
profile, while ignoring all other genes. Consequently “TN” statistics is not 
straightforward to evaluate in this context. 
Performance evaluation was done in both A. thaliana and M. truncatula. The 
extracted genomic sequences were used as input sequences. I evaluated the pipeline 
performance using each of the “GeneID”, “Augustus_de_novo”, “GlimmerHMM”, 
“GeneMark”, “GeneWise+SplicePredictor”, “Augustus_evidence” component 
(individually), as well as “SPADA” (combination of “GeneWise+SplicePredictor” and 
“Augustus_evidence”) and “All” (combination of all 6 individual components). All 
programs were installed and run locally on a GNU/Linux workstation. The appropriate 
parameter files, model files and training directories, if available, were used to run these 
programs in each species, otherwise the default parameter files (which are for 
Arabidopsis) were used. The outputs of these runs were parsed to derive a unique 
prediction for each test sequence. 
RNA-Seq and microarray processing, data visualization 
I mapped the RNA-Seq short reads (downloaded from NCBI SRA) to the reference 
using TopHat and summarized the results using Cufflinks (Trapnell et al. 2012). 
Cufflinks is able to estimate the expression value at the level of transcripts. I used a 
cutoff of FPKM (Fragments Per Kilobase of exon model per Million mapped fragments) 
> 1 to determine if a model (either in the test set or in the SPADA prediction set) is 
expressed. 
For the AtMtDEFL array, PMA (Present, Marginal and Absent) calls and normalized 
expression values of each probe set were obtained from the supplemental tables of two 
recent papers (Nallu et al. 2013; Tesfaye et al. 2013). I mapped the probe sequences to 
the transcript models in the test set as well as SPADA prediction. In many cases the 
annotated gene boundaries are not complete and lack portions of the 3’-UTR that is 
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prioritized in Affymetrix designs, and the probes designed in these regions would not be 
mapped. As a result, I require at least six probes in a probe set matching the target gene 
(with 23 or more identical nucleotides for each 25-mer oligo probe). Finally, the PMA 
calls of a probe set should be ‘Present’ in at least one tissue/treatment condition to 
indicate expression support for the transcript model it is mapped to. 
In order to visualize some of the novel SPADA predictions as compared to the 
original genome annotation, as well as the underlying RNA-Seq read mapping support, I 
loaded the data (genome sequence file, annotation GFF file, SPADA prediction GFF file, 
RNA-Seq mapping BAM file) into IGV (Integrative Genomics Viewer) (Thorvaldsdóttir, 
Robinson, and Mesirov 2013), adjusted the width of each track, and made screenshots. 
Results 
Performance evaluation of SPADA on plant Cysteine Rich Peptide (CRP) 
families 
SPADA performance under different search E-value thresholds 
Using our manually curated high-quality CRP test set from Arabidopsis and 
Medicago, I first evaluated the performance of SPADA under different search E-value 
thresholds. Generally speaking, with a loose E-value threshold (e.g., 0.1), SPADA is able 
to predict almost all true models (i.e., achieving high sensitivity) while making many 
false predictions (i.e., specificity is low) (Appendix Figure 1.1). By setting the search 
threshold to a more stringent value, SPADA avoids making most of the false predictions, 
but also loses a small number of true models. In an effort to optimize search sensitivity 
(the ability to detect all true gene models) and specificity (preventing the detection of 
spurious false models, refer to the “Method - Performance evaluation - Evaluation 
procedure” section for a formal definition of sensitivity and specificity), I set the default 
search E-value threshold to 0.001. Users can also change the default E-value threshold to 
build custom searches (e.g., a very sensitive search using E-value cutoff of 1 to identify 
all potential hits). 
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Performance comparison of different gene prediction components 
I then compared the performance of SPADA running different model prediction 
components: GeneID, Augustus (“de novo” mode as well as “evidence” mode), 
GlimerHMM, GeneMark, GeneWise+SplicePredictor as well as “SPADA” (combination 
of “Augustus_evidence” and “GeneWise+SplicePredictor”) and “All” (combination of all 
6 individual components) (Figure 1.2, Appendix Figure 1.1). The high specificities 
observed in all components are likely due to the model evaluation and selection step, 
where most false models are filtered. Prediction sensitivities, on the other hand, show 
substantial differences among components. In both genomes tested, “Augustus_evidence” 
and “GeneWise+SplicePredictor” gave the highest sensitivities among the six individual 
components. The default SPADA pipeline (denoted as “SPADA” in the figure) runs these 
two components and achieved even higher sensitivity. On the other hand, running all six 
individual components (denoted as “All” in the figure) gives the highest sensitivity, 
suggesting that search accuracy can still be improved by including more heterogeneous 
prediction programs in the pipeline. However, the gain in sensitivity offered by running 
all six components is marginal compared to running just two of them 
(“Augustus_evidence” and “GeneWise+SplicePredictor” ), suggesting that a plateau in 
search accuracy could soon be reached and adding more prediction programs in the 
pipeline may not help much. 
These results are expected as SPADA does not work as a general gene finding 
program but instead focuses on particular classes of genes with known profiles. Small 
genes are typically difficult to predict and often missed by genome annotation pipeline 
due to the intrinsic properties of many automatic gene finding algorithms (Haas et al. 
2005). In my test with GeneID, Augustus and GlimmerHMM against the Medicago 
genome, the Arabidopsis training matrix was used since a Medicago specific one is not 
yet available. This explains to a large extent the extremely low sensitivity performance 
for these three programs in Medicago. Search specificities were generally quite high and 
did not vary much among different programs or genomes tested, indicating the relatively 
stringent search E-value (0.001) in effect allows few false positives. 
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Cysteine-rich peptides predicted by SPADA in Arabidopsis and Medicago 
Using the default search E-value threshold and model prediction components, 
SPADA predicts 745 CRPs in Arabidopsis and 1170 (747 for CRP0000-CRP1530) in 
Medicago (Table 1.1, Appendix Table 1.1-1.2, Appendix Figures 1.2-1.3, Appendix File 
1.2). These numbers are generally consistent with our manually curated CRP test sets 
(742 for Arabidopsis) and 725 for Medicago (Silverstein et al. 2007), with a sensitivity of 
91%–93% and specificity of 85%–95% at the nucleotide level (Appendix Figure 1.1). 
Members within a sub-class typically show a conserved signal peptide and cysteine 
configuration (Appendix Figure 1.4 for example). I also checked the expression of these 
predictions using publicly available RNA-Seq data from NCBI: 570 (76.5%) out of the 
745 Arabidopsis CRPs and 947 (80.9%) out of the 1170 Medicago CRPs receive either 
RNA-Seq or AtMtDEFL array expression support (Appendix Table 1.5-1.6). It should be 
noted that SPADA makes no attempt to predict pseudogenes as it filters out hits with in-
frame stop codons. However, some pseudogenes with premature stop codons might still 
be predicted by SPADA as valid gene models if the in-frame part shows significant 
(though incomplete) similarity to the search HMM. This in part explains the higher 
number of SPADA predictions (747 for CRP0000-CRP1530) in Medicago than the test 
set (725) since pseudogenes were manually removed to obtain the test set. 
The default E-value threshold of 0.001 is a compromise between sensitivity and 
specificity that generally works well for both organisms. For the purpose of identifying 
all potential small coding genes, a search with high sensitivity should be performed since 
it allows the user to see all potential hits and then determine for him/herself the boundary 
between false predictions and true predictions based on search scores. The users can then 
set the cutoff threshold empirically and select genes for experimental verification on their 
own. Thus, two CRP prediction sets by running SPADA using E-value threshold of 1 
were also reported here (Appendix Table 1.7-1.8). In practice, users are encouraged to 
change the default E-value threshold to build custom searches. 
According to the latest versions of genome annotation for Arabidopsis and 
Medicago, about 5% to 15% of SPADA predictions fall completely into intergenic 
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regions (i.e., are un-annotated, Table 1.2). Through manual inspection of these models, 
we found that some of the unannotated models turn out to be ORFs with premature stop 
codons (i.e., pseudogenes), while others had quite significant hmmsearch E-value and 
complete ORFs. In addition, some predicted models receive expression support from 
either existing EST sequence or RNA-Seq data. An example is shown in Figure 1.3 
where the predicted CRP model is supported by RNA-Seq mapping, fits well in the 
family-specific alignment, but was missed by the genome annotation (Medicago genome 
annotation version 3.5) as well as by our test set. While such cases are infrequent (e.g., 
only 10 in Arabidopsis), I speculate the specificity of SPADA is likely to be 
underestimated. 
I then performed manual inspection on these unannotated CRP models and tried to 
determine whether the calls are truly bad predictions (e.g., pseudogenes with pre-mature 
stop codons) or valid members of the family missed by current genome annotation 
(criteria being that the predicted model fits well in the family-specific alignment and has 
either RNA-Seq or Affymetrix expression support). The number of “novel” CRPs 
discovered in this fashion, is given in Table 1.2 (Appendix File 1.3). SPADA was able to 
identify 77 novel CRPs in Medicago that were missed by current genome annotation 
pipeline. The actual number of new CRPs in Medicago will be even higher since we only 
evaluated a subset of all CRP groups (CRP0000-CRP1530). This result is not unexpected 
given that the Medicago genome was released only recently and resources and efforts put 
into the genome annotation pipeline have been limited. On the other hand, only 3 novel 
CRPs were found in Arabidopsis, suggesting a relatively higher quality of gene calls in 
this extensively studied model organism. 
Through examination of the novel CRPs, I also noticed that while some of the novel 
hits have a very significant hmmsearch E-value (e.g., 10−12), most have moderate E-
values (e.g., 10−4-10−7), suggesting that their sequence similarity to the input HMM 
profile is limited. While the input profile alignments were manually built and may not be 
exhaustive in capturing all groups of CRPs, I speculate that some of these novel CRPs 
might form new clades that define novel profile alignments, separate from the original 
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alignment. Consequently, a new round of genome scans using these novel profiles has the 
potential for capturing even more members that have been missed in the previous search. 
Case study: the S-Protein Homologue (SPH) family in Arabidopsis 
In addition to plant CRPs, SPADA is readily generalizable to other classes of 
putative secreted peptides by substituting an appropriate set of HMMs in place of CRP 
HMMs. Here, the SPH peptides (S-Protein Homologue) (Foote et al. 1994) were used as 
an example. A seed alignment including 45 plant self-incompatibility protein S1 
sequences (PF05938) was obtained from the Pfam database. An HMM profile was built 
from this alignment and then used as input to scan the Arabidopsis genome (TAIR10) 
(Lamesch et al. 2012) by running SPADA. SPADA predicted 92 SPH peptides in total 
(Appendix Table 1.9, Appendix File 1.4). Forty-five (45) of these predictions are 
identical with TAIR10 annotation. Seventeen have minor discrepancies with TAIR10 
gene models (coding regions all in the same reading frame but have a boundary conflict 
of less than 15 amino acids, probably resulting from different start codons or alternative 
splice sites). Nine are in major conflict with existing gene models (coding regions in 
different reading frames or having serious boundary conflict). I also discovered 21 new 
SPHs not present in TAIR10. Through manual inspection of gene models and sequence 
alignments with other family members, 3 out of the 15 major conflicts were found to 
reflect an error in TAIR10 (Figure 1.4A gives an example), while 19 out of the 21 models 
absent from TAIR10 are true members of the SPH family, missed by the current genome 
annotation (Figure 1.4B shows an example). As such, I demonstrate that SPADA 
accurately detects other classes of secreted peptides given a well-constructed profile 
alignment. 
Case study: a fungal cyclic peptide family in Amanita bisporigera 
In order to assess whether SPADA could be useful in searches for families of small 
non-secreted peptides outside the plant kingdom, I also examined the fungal cyclic 
peptides of Amanita mushrooms (Hallen et al. 2007). This family includes the amatoxins 
and phallotoxins, such as α-amanitin and phalloidin, respectively, which are synthesized 
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as proproteins of 34-35 amino acids. I began by creating a multiple sequence alignment 
via ClustalO of reported proproteins (Hallen et al. 2007) and executed SPADA as usual 
with the signal peptide filter turned off, using Arabidopsis as the training model for 
Augustus in searching the low-coverage genome contigs of Amanita bisporigera. As a 
negative control, I scanned the genome of Amanita thiersii, which is non-toxic and not 
known to produce this class of toxins. 
SPADA identified five new peptides in the incomplete A. bisporigera genome with 
strong homology (2.4×10−17 < E < 5.8×10−8) that fit well with the alignment of known 
proproteins (Figure 1.5). One additional hit ran off the end of the contig, producing the 
incomplete propeptide “MSDTNVMRLPFTTP”. No additional predictions were made by 
SPADA with E < 0.01 beyond sequences that were already included in the original 
alignment. Further, SPADA did not identify any hits when scanning the genome of A. 
thiersii, as would be expected from that organism’s non-toxic nature. 
Discussion 
Homology-based gene prediction 
Unlike general-purpose gene predicting programs, SPADA works as a family-based 
gene finder. The major difference between SPADA and general gene predicting programs 
is that it incorporates prior information from the family profile in the prediction process. 
SPADA takes advantage of generic gene prediction programs, but goes a step further by 
suggesting where to look for family members. Through scanning the target genome using 
pre-built family-specific alignments, SPADA identifies and builds “extented hits” that 
serve as the backbone of the underlying exonic structure. This location information 
greatly improves prediction accuracy, as shown by the different performances of 
“Augustus_de_novo” and “Augustus_evidence” components in Figure 1.2. Among the 
six individual predicting components, the four that do not require additional information 
and make de novo predictions all yield low sensitivities. The other two approaches, 
“Augustus_evidence” and “GeneWise+SplicePredictor”, make use of the location 
information and are able to predict most of the true positives. 
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Family-based gene prediction was first introduced in the AUGUSTUS package as 
the AUGUSTUS-PPX (Protein Profile eXtension) module (Keller et al. 2011). Although 
AUGUSTUS-PPX was shown to be more sensitive and accurate in predicting long, 
multi-exon gene family members than the standard AUGUSTUS algorithm, its approach 
is not suitable for small, divergent peptide families such as CRPs, SPHs or Amanita 
toxin-like peptides examined here. Rather than using the entire protein family alignment 
profile as input, AUGUSTUS-PPX makes use of conserved, ungapped blocks from the 
alignment to make a profile. This enables the algorithm to identify core match regions in 
the genome sequence which together act as a scaffold in the gene prediction. A 
modification of the standard AUGUSTUS gene-centric HMM is then used to fill in the 
pieces between scaffold elements with splice elements and other signals, ultimately 
emitting the most probable full gene structure. While this approach works well for 
families of typical genes with large numbers of conserved elements, it completely breaks 
down when applied to small, divergent peptide families like the CRPs, as these families 
tend to contain no conserved, ungapped regions of appreciable size to seed the initial 
scaffold. Indeed, when we applied AUGUSTUS-PPX to the CRPs we observed no 
improvement over “Augustus_de_novo”. 
Improving prediction accuracy by model evaluation 
The default SPADA pipeline (running the “Augustus_evidence” and 
“GeneWise+SplicePredictor” components) achieves even higher sensitivity than the two 
individual components. This owes to the model evaluation & selection step. For each 
HMM hit, SPADA collects all candidate gene models built by its model predicting 
components, and in the model evaluation step, picks a best candidate model based on 
multiple evaluation statistics. True family members will probably get a high-scoring gene 
model, while most false positive hits will have no qualifying or only low-scoring gene 
models built. High-scoring gene models that passed the filter are more likely to be true 
models since they are the ones that best fit the family-specific alignment. 
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Pseudogenes and gene models without expression evidence may still have 
significant value 
SPADA identifies paralogous gene family members throughout the genome. Many 
of these predictions currently lack expression evidence and some of the gene predictions 
have premature stop codons suggesting they may be psuedogenes. Nonetheless, it is 
important to identify all gene family members, regardless of their expression and 
pseudogene status, especially in evolutionarily dynamic gene families. The semi-
automated approach that inspired SPADA’s development identified hundreds of 
defensin-like genes in Arabidopsis which, at the time, had no expression evidence 
(Silverstein et al. 2005). Later, these genes turned out to be highly specifically expressed 
in reproductive tissues not previously examined with earlier genome-wide expression 
approaches (Jones-Rhoades, Borevitz, and Preuss 2007). Moreover, one must also be 
careful not to discard pseudogene predictions that are highly similar to other family 
members. A gene that appears as a pseudogene in the reference sequenced accession of a 
species may indeed be fully intact in other accessions, as observed among the defensin-
like pollen-tube attractant, AtLUREs (. In their study, Takeuchi and Higashiyama 
observed half a dozen AtLUREs with disabling mutations in non-reference accessions, as 
well as putative functional and intact forms of AtLUREs 1.5 and 1.6, which are 
pseudogenes in the reference Col-0 genotype (Takeuchi and Higashiyama 2012). 
Improving SSP annotation in current plant SSP databases 
Previous work has sought to exhaustively identify small secreted peptides (SSP) in 
Arabidopsis (Lease and Walker 2006), rice (B. Pan et al. 2013) and Populus deltoides 
(Yang et al. 2011). These earlier studies only scanned short ORFs (25-250 amino acids) 
in translated genome sequence, though Pan et al. (B. Pan et al. 2013)did include multiple-
exon gene predictions from ab initio gene predition programs such as Fgenesh and 
Augustus. However, with a primary focus on detecting all small secreted peptides, these 
studies did not utilize protein family information in the model building process since 
secreted peptides are so diverse. The Arabidopsis Unannotated Secreted Peptide Database 
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(AUSPD) only contains one-exon ORF predictions, and thus mis-annonates most (if not 
all) two-exon secreted peptides (Appendix Figure 1.5 for example). The OrysPSSP 
database (comparative Platform for Small Secreted Proteins from rice from rice and other 
plants) does contain multi-exon models predicted by Fgenesh (0.72%) and Augustus 
(1.16%) in addition to single-exon ORFs (B. Pan et al. 2013). However, since no prior 
information is incorporated into predictions by these ab initio gene predicting programs, 
multi-exon models in OrysPSSP are frequently in conflict with the true rice CRPs 
(Appendix Figure 1.6 for example). As a result, while most single-exon peptides in 
Arabidopsis and rice are captured in AUSPD and OrysPSSP respectively, a large portion 
of the two-exon and multi-exon genes (such as CRP0000-CRP1530) are clearly under-
represented in these two databases. SPADA, on the other hand, used additional gene 
structure information obtained in the motif mining step and was able to correctly predict 
most of the CRP models (Appendix Table 1.10). 
Complementarity of SPADA to generic gene prediction programs 
SPADA is not designed to identify all genes in a genome. However, its applicability 
to new annotation projects steadily will increase due to the marked growth of protein 
sequence family signatures and alignments. InterPro release 43.0 contains 16,652 protein 
family signatures. In the last 3 years, the number of families characterized by InterPro has 
increased by 24%, compared with a 38% increase in the 3 years prior to that (Hunter et 
al. 2012). (Release 29.0 from October 2010 had 13,382 family entries; Release 16.1 from 
October 2007 had 9,729 entries.) 
It should be noted that SPADA is unlikely to perform well with genes that have large 
numbers of exons due to the combinatoric explosion of potential splice donor and 
acceptor pair combinations to evaluate. For longer multi-exon gene families, 
AUGUSTUS-PPX should be used. Still, SPADA has been shown here to be extremely 
effective in predicting families of one- and two- exon genes often missed or excluded by 
standard gene prediction algorithms (Basrai, Hieter, and Boeke 1997; Lease and Walker 
2006). Hence, it is anticipated that gene annotation pipelines would be improved by 
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routinely running SPADA to pick up small genes in addition to the standard generic gene 
prediction algorithms (e.g., Augustus) for larger genes. 
Impact of better gene prediction algorithms on plant genomics 
As sequencing costs have come down, there has been a commensurate expansion in 
the sequencing of multiple plant genomes within each species. Moreover, Genome Wide 
Association (GWA) studies are now routinely carried out in these populations. Gene 
annotation cannot be simply transferred across members of a species due to the myriad of 
SNPs and indels that alter gene structures. Gan et al. estimated that gene structural 
changes occurred in more than 30% of genes among the 18 Arabidopsis accessions they 
resequenced and assembled (Gan et al. 2011). Further, GWA studies have repeatedly 
implicated unannotated intergenic regions as having the most significant association with 
important agronomic traits (Brachi et al. 2010; Kump et al. 2011). While it is likely that 
many of these GWA peaks identify non-coding RNAs or regions in strong linkage 
disequlibrium with causative variants, we suspect that many of these sites may actually 
mark members of as yet unannotated families of small genes. Indeed, in a recent GWA 
study (Stanton-Geddes et al. 2013), many peaks turned out to coincide with NCR or other 
CRP family members that prior to our intensive family-based annotation studies had been 
un-annotated in Medicago. 
Discovery of genes resembling Nodule-Cysteine-Rich (NCR) peptides in 
Arabidopsis 
In striking contrast to Arabidopsis, the Medicago genome harbors a huge number 
(583 versus 3) of Nodule Cysteine-Rich peptides (NCRs, CRP1130-CRP1530) – 
Defensin-Like proteins with nodule-specific expression (Table 1.1). These NCRs are 
unique to Medicago (specifically, legumes in the Inverted Repeat-Lacking Clade) 
(Silverstein, Graham, and VandenBosch 2006) and have recently been shown to play 
vital roles in the communication between Medicago and symbiotic rhizobia (Wang et al. 
2010; Van de Velde et al. 2010; Farkas et al. 2014). 
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Surprisingly, three CRPs were found in the Arabidopsis genome falling into the 
nodule-specific sub-families (CRP1130-CRP1530, or NCRs). Previously, NCRs were 
thought to be unique to Medicago and other IRLC legumes, playing a vital role in the 
legume-rhizobia symbiotic interaction (Mergaert et al. 2003). Looking closely at the 
sequence alignments (Appendix Figure 1.7), these “Arabidopsis NCRs” have all the 
conserved cysteine residues in the expected configuration, while also exhibiting 
substantial divergence from Medicago NCRs - and forming a separate Arabidopsis-
specific clade. Furthermore, only one Arabidopsis NCR is predicted in each sub-class. It 
is possible, therefore, that these “Arabidopsis NCRs” are descendants from the most 
recent common ancestral genes that later evolved into Medicago NCRs. After the 
Arabidopsis-Medicago divergence, these ancient NCRs could have become increasingly 
divergent in the legume (Medicago) clade, eventually gaining new functions in nodule 
development and symbiosis, possibly through neo-functionalization, conferring a 
selective advantage and thus increasing rapidly in copy number through gene duplication. 
Limitations of the SPADA pipeline 
Because the model prediction step in the pipeline is not optimized for multi-exon 
gene models nor the extremely large introns present in animal genomes, I do not yet 
recommend SPADA to identify small peptides in animals (especially mammals). Also, 
SPADA is not expected to work well with bacterial genomes due to the absence of 
introns in their gene models. However, this pipeline will work well with organisms such 
as yeast, oomycete and fungi, since they have similar gene structures to plants (Galagan 
et al. 2005; Saxonov et al. 2000). In fact, it was recently found that oomycetes and fungi 
genomes encode large number of secreted effectors as a result of the evolutionary “arms-
race” between pathogen and host (Haas et al. 2009; Spanu et al. 2010). Potentially, 
SPADA will be useful in effector discovery in these pathogen genomes given that a 
growing number of informative family alignments are becoming available. 
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The SPADA pipeline is useful beyond secreted peptides and outside plants 
Although SPADA was initially designed to target secreted peptide families in plants, 
it can be used on non-secreted peptide families, especially in fungal systems. In the 
Results section, I tested SPADA using draft genome contigs of the mushroom A. 
bisporigera in search of additional members of a class of potent liver toxin pro-peptides 
characterized in earlier work (Hallen et al. 2007). Roughly 20 pro-peptides belonging to 
this family had been cloned and sequenced, with only about a dozen present among the 
draft genome sequence contigs. SPADA identified 5 new family members with 
convincing alignments and significant E-values (2.4×10−17 < E < 5.8×10−8). Three of 
these were in contigs long enough that extensive homology in the 3’-UTR region 
characteristic of the family could be observed. The contigs of the remaining two hits 
ended shortly after the coding sequence preventing 3’-UTR homology characteristics 
from being confirmed. When the same input HMM constructed from the known 20 pro-
peptides (Hallen et al. 2007) was used to scan against a related mushroom Amanita 
thiersii that is known not to produce toxic peptides, SPADA did not identify any 
candidate genes with E < 0.01. 
Conclusions 
SPADA is a homology-based gene prediction program to accurately identify and 
predict the gene structure for short peptides with one to a few exons. SPADA works well 
on small plant peptides such as the cysteine-rich peptide families. SPADA gives much 
more accurate and precise gene calls than traditional ab initio gene finding programs in 
tested genomes. Running SPADA on less well-annotated plant genomes (e.g., Medicago) 
reveals numerous mis-annotated and unannotated CRPs in the current genome 
annotation. Predictions made by SPADA constitute the most complete set of plant 
cysteine-rich peptides, and in this regard, will provide an invaluable resource for the 
research of small, secreted peptides in plants. The systematic application of SPADA to 
other classes of small peptides by communities will greatly improve the genome 
annotation of different protein families in public genome databases.  
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Table 1.1. Cysteine-Rich Peptides (CRPs) predicted in A. thaliana and M. 
truncatula 
 Subgroup ID# A. thaliana M. truncatula 
Defensin related CRP0000-CRP0260,etc. 56 43 
LCR/BET1 related CRP0280-CRP0810,etc. 162 110 
SCR related CRP0830-CRP0880 32 6 
Metallocarboxypeptidase inhibitor CRP1004-CRP1030 0 1 
CCP related CRP1040-CRP1120 19 4 
Nodule Cysteine-Rich peptide CRP1130-CRP1530 3 583 
Ripening related protein CRP1600-CRP1605 0 21 
Novel family CRP1620,CRP2800,etc. 14 15 
Miscellaneous CRP1640-CRP1660,etc. 16 48 
Rapid Alkalinization Factor CRP1700-CRP2120 38 36 
Thionin related CRP2200-CRP2610 66 23 
Root cap/late embryogenesis CRP2820-CRP2850 5 7 
Antimicrobial peptide MBP-1 CRP2900-CRP3000 1 2 
Bowman Birk inhibitor CRP3100-CRP3190 0 16 
Pollen Ole e I CRP3300-CRP3510 34 44 
ECA1 gametogenesis related CRP3600-CRP3740 124 17 
Lipid transfer protein CRP3800-CRP4962 127 127 
2S Albumin CRP4970-CRP5080 5 3 
Glutenin/Giadin/Prolamin CRP5090-CRP5270 0 0 
Maternally-expressed gene/Ae1 CRP5300-CRP5520 20 2 
Proteinase inhibitor II CRP5545-CRP5600 6 2 
Chitinase/Hevein CRP5610-CRP5820 10 15 
Kunitz type inhibitor CRP6010-CRP6180 7 45 
Total  745 1170 
#CRP subgroup identifiers as assigned in Silverstein et al. (Silverstein et al. 2007). 
 
 !
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Table 1.2. Manual inspection confirms novel CRP models predicted by 
SPADA. 
 A. thaliana M. truncatula 
Total predictions 745 1170 
Number of unannotated predictions# 5 125 
Number of novel models% 3 (60%) 77 (62%) 
#An unannotated prediction is a gene model predicted by SPADA but missed by current genome 
annotation.  
%Novel models are unannotated predictions that are manually inspected to be true members of the 
family with evidence from family-specific alignment and/or RNA-Seq evidence.  
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Figure 1.1. The SPADA workflow. 
In the pipeline, SPADA first builds family-specific multiple sequence alignments and prepares 
genomic and protein sequences (Pre-processing). It then runs HMMer to identify hits in the target 
genome sequence and proteome sequence (Motif Mining). Next, SPADA runs several gene 
predicting programs (components) to generate candidate gene models (Model Prediction). 
Finally, SPADA picks the best candidate models for each hit based on multiple statistics (Model 
Evaluation & Selection). 
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Figure 1.2. Performance comparison of different gene prediction components.  
Search E-value threshold is set to 0.001 by default. 
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Figure 1.3. A novel gene model predicted by SPADA is missed by the current 
Medicago annotation.  
A Medicago NCR (h1001.01, track “SPADA”) and subgroup alignment of CRP1180 
with h1001.01 shaded. 
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Figure 1.4. SPADA detects mis-annotated and novel SPH peptides in TAIR10. 
(A) SPADA detects an SPH peptide (h0018.02) that is mis-annotated in TAIR10; (B) 
SPADA detects a novel SPH peptide (h0013.02) not present in TAIR10. Multiple 
sequence alignment of selected SPH peptides are shown below with h0018.02 and 
h0013.02 shaded. 
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Figure 1.5. Multiple sequence alignment of Amanita toxin proproteins. 
Sequences identified by SPADA are labeled as “hm****”. All remaining sequences were 
obtained from Hallen et al. (Hallen et al. 2007), and were included in the initial alignment 
used as input for SPADA. 
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Chapter 2. The Medicago Pan-16 genome enables exploration 
of novel genetic variation 
Medicago truncatula is a model for investigating legume genetics and the evolution 
of legume-rhizobia symbiosis. Previous studies using whole-genome sequence data to 
identify sequence polymorphisms (SNPs and short Insertion/Deletions) relied on 
mapping short reads to a single reference genome. However, limitations of read-mapping 
approaches have hindered variant detection in repeat-rich and highly divergent regions, as 
well as studies of large gene families potentially involved in disease resistance and plant-
microbe symbiosis. De novo assembly and annotation of the genomes of 15 M. truncatula 
accessions allowed me to detect novel genetic variation that would not have been found 
by mapping reads to a single reference. This analysis leads to a within-species diversity 
estimate nearly 70% higher than previous mapping-based resequencing efforts, even 
based on a smaller sample size. The results clearly demonstrate that de novo assembly-
based comparison is more accurate and precise than reference mapping-based variant 
calling in exploring variation in repetitive and highly divergent regions. For the first time 
in plants, this work systematically identified and characterized different types of SVs 
using a synteny-based approach. The results suggest that, depending on the divergence 
from the reference accession, as much as 7% to 21% of the entire genome is involved in 
large structural changes, altogether affecting 10% to 28% of all gene models. Based on 
genome-wide synteny alignments against the reference genome, these results identified 
63 Mbp unique sequence segments absent in the reference, including 30 Mbp shared by 
at least two accessions and 34 Mbp of accession-specific sequences, thus expanding the 
published reference space for Medicago (389-Mbp) by 16%. Pan-genome analysis 
suggests a “restricted” pan-genome (450 Mbp) and core-genome size (270 Mbp) curve, 
both beginning to level off when ten or more accessions become sequenced. This work 
illustrates the value of multiple de novo assemblies and the strength of comparative 
genomics in exploring and characterizing novel genetic variation within a population, 
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providing insights into the impact of structural variation on genome architecture and large 
gene families underlying important traits.  
  34 
Introduction 
A better understanding about the nature and extent of genome variation within M. 
truncatula is critical for both practical and scientific reasons. The high quality, BAC-
based sequence of the Medicago A17 genome has served as the “reference genome” for 
the Medicago research community. This reference genome assembly (version 4.0) covers 
~80% of the overall genome (estimated at 465 Mbp) while capturing ~93% of all 
predicted gene models (Bennett and Leitch 2011; Tang et al. 2014). Recently, 
resequencing of additional Medicago accessions from diverse geographic locations has 
enriched the pool of sequence information available for Medicago (Branca et al. 2011; 
Stanton-Geddes et al. 2013). However, these studies relied on mapping short reads to a 
reference sequence in order to call polymorphic sites (i.e., read mapping-based 
approach). This introduces a potential bias due to significant structural differences 
between diverse Medicago accessions. Alignment to a single reference is most 
problematic when reads from a divergent Medicago accession, such as the functionally 
important R108, are incorrectly aligned to the A17 reference due to mis-alignment of 
paralogous regions. With a high within-species nucleotide diversity (genome-wide 
estimates of θw = 0.0063 and θπ = 0.0043 bp−1 approximately three times more than found 
in soybean θw-cultivated = 0.0017 bp−1 and θw-wild = 0.0023 bp−1 populations), it may not be 
surprising that only a portion of the (reference) genomic regions can be confidently 
probed with read-mapping approaches. Diversity estimates may thus be underestimated 
due to the elimination of divergent (un-aligned) sequences. In addition, the length 
limitation of short read technologies such as Illumina leads to ambiguous mappings in 
repetitive and duplicated regions. Finally, the incompleteness of the reference genome 
limits our ability to detect variation in regions not present in the reference (e.g., assembly 
gaps) and leads to false alignments and SNP calls if reads from these regions align to 
their next best match. Taken together, over-reliance on read mapping-based approaches 
have hindered our understanding of the types and extent of genomic diversity in 
Medicago. 
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Structural variants (SV) include unbalanced copy number variation such as deletions, 
insertions and duplications, as well as balanced variants such as inversions and 
translocations (Weischenfeldt et al. 2013). In the case of humans, research suggested the 
number of nucleotide differences between individuals due to SVs is greater than that due 
to SNPs (Redon et al. 2006). Studies of model organisms such as Arabidopsis, 
Drosophila, humans, and maize have also revealed considerable levels of segregating 
structural polymorphism (Korbel et al. 2007; Emerson et al. 2008; Kidd et al. 2008; 
Swanson-Wagner et al. 2010; Cao et al. 2011; McVean et al. 2012). As a major 
contributor to genetic variation, genomic SV is thought to be an important factor in 
determining phenotypic variation for a wide range of traits, such as the digestion of 
starchy foods in humans (Perry et al. 2007), dwarfism and flowering time in wheat 
(Triticum aestivum) (S. Pearce et al. 2011; Díaz et al. 2012), insecticide and virus 
resistance in Drosophila melanogaster (Schmidt et al. 2010; Magwire et al. 2011) and 
resistance against soybean cyst nematode conferred by the Rhg1 locus (Cook et al. 2012). 
Owing to inherent difficulties in their ascertainment, however, SVs have remained a 
relatively poorly understood form of genetic variation in comparison to SNPs. 
The distribution of structural variation (SVs) in the Medicago and their impacts on 
genome architecture and important gene families remain largely unknown, yet essential 
in gaining insight into the genetic basis of legume-rhizobium symbiosis and identifying 
genes underlying phenotypic variation. The only practical way to understand the genomic 
diversity of Medicago fully and to capture the numerous members of divergent gene 
family members is to carry out whole genome sequencing and de novo assembly. Recent 
advances in NGS chemistry and computational approaches in sequence assembly have 
significantly improved the power and reliability of de novo assembly of NGS data. In this 
study, I analyzed de novo genome assemblies of 15 strategically chosen Medicago 
accessions. Working with colleagues, I constructed a Medicago Pan-16 genome and 
proteome, and fully characterized the genomic content and gene family repositories for 
these accessions. I performed whole genome alignment against the HM101 reference, 
constructed genome-wide synteny blocks and identified of extensive variation including 
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SNPs, Indels and complex SVs for each accession. The results showed that traditional 
variant detection approach based on mapping reads to a single reference genome is much 
less accurate than the synteny-based variant calling approach especially in repetitive and 
highly divergent genomic regions. We found that diversity estimates were significantly 
underestimated by previous mapping-based variant detection approach and were able to 
determine the extent and distribution of SVs that were not detectable by previous 
approaches. This work illustrates the value of multiple de novo assemblies in building 
and characterizing plant pan-genomes and provides insights in understanding the impact 
of different types of SVs on genome architecture and large gene families underlying 
important traits. 
Methods 
Plant material 
Fifteen M. truncatula accessions from geographically distinct populations (Figure 
2.1) broadly spanning the entire Medicago species range were chosen for deep 
sequencing and de novo assembly. These accessions were chosen for both biological 
interest and to facilitate evaluation of assemblies. In particular, 3 accessions were 
selected from the A17 (reference) clade, nine were selected from the France-Italy clade 
and 3 were picked from more distantly related clades. While most analyses were done on 
all 16 accessions including the reference HM101, some statistics sensitive to population 
structure were derived from a subset of 13 accessions (16 excluding the 3 distant 
accessions), which we refer to as “ingroup” accessions. Each accession was self-fertilized 
for 3 or more generations before growing seedlings for DNA extraction. Cloning and 
sequencing grade DNA was extracted from a pool of ~30 day old dark-grown seedlings 
by Amplicon Express (Pullman, WA) through Ultra Clean BAC Clone Prep followed by 
a CTAB liquid DNA prep.  
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Sequencing and genome assembly 
Library preparation, sequencing and assembly described herein were performed at 
the National Center for Genome Resources (NCGR) in Santa Fe, NM. DNA sequencing 
was performed using Illumina HiSeq 2000 instruments. For each of the fifteen 
accessions, we made and sequenced one Short Insert Paired End library (SIPE) and either 
one or two Long Insert Paired End (LIPE) libraries following the requirements and 
recommendations of the ALLPATHS-LG whole genome assembler (Gnerre et al. 2011). 
The SIPE library is a 180 bp fragment library sequenced as 2 × 100 bp reads, while the 
two LIPE libraries are jumping libraries with insert sizes around 5 kbp and 9 kbp, and 
sequenced as 2 × 50 bp and 2 × 100 bp reads, respectively. 
For the SIPE library the sample was mechanically fragmented by using the Covaris 
S2 System and then prepared based on the Kapa Hyper Prep Kit and ligated to standard 
Illumina paired-end adapters. Blue Pippin size selection was done to yield fragments of 
300 nucleotides (180 nucleotides plus adapters). 
For the LIPE libraries, either the Illumina or Nextera mate-pair library protocol was 
used. The DNA was size selected at 5 kb for the Illumina libraries or, using the Blue 
Pippin, at 9 Kb for the Nextera libraries. Nextera libraries were fragmented using the 
Covaris S2 System. Each of the libraries was sequenced to 40x to 100x sequence 
coverage, as recommended by the assembler algorithm (Appendix Table 2.1). 
ALLPATHS-LG assembly algorithm (version 49962) (Gnerre et al. 2011) was run on a 
linux server with default parameters to complete the assembly. 
PacBio long read data was also generated to validate the identified structural 
variation in three accessions including HM034, HM056 and HM340. Sequencing was 
done using P4C2 chemistry and Smrtanalysis version 2.1 or P5C3 chemistry and 
Smrtanalysis version 2.3. Reads were filtered at minimum quality of 75, minimum sub-
read length of 50 bp and minimum read length of 50 bp. Final coverage for each 
accession was estimated to be 18-20 fold. 
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Genome size estimates for Medicago accessions 
Seeds of nine Medicago accessions (HM004, HM005, HM006, HM029, HM030, 
HM034, HM056, HM101 and HM324) were obtained from the Medicago HapMap 
project (http://www.medicagohapmap.org/). Seeds of known genome size standards were 
obtained from Dolezel et al. (Jaroslav Doležel and Bartoš 2005). Seedlings were grown 
in a growth chamber at 25°C under identical light and humidity conditions. Samples of 
leaf nuclei were prepared essentially following the procedure of Dolezel et al. (Jaroslav 
Doležel and Bartoš 2005) using Galbraith’s buffer (Galbraith et al. 1983). Samples were 
analyzed on a BD FACSCalibur flow cytometer at the Biodesign Institute, Arizona State 
University. Mean DNA content was based on 15,000 nuclei, with peak means identified 
using CellQuest software (Becton Dickson). Calculation of genome size used the sample 
peak mean divided by the standard peak mean, multiplied by the genome size of the 
standard. Each plant accession was sampled three or more times on different days to 
minimize the effect of instrument drift and other variables. For most accessions three or 
more different plants were sampled, but occasionally only two plants were sampled. 
Values reported are averages of the samples from each accession. We used a value of 2.3 
pg for the genome size of Glycine max Polanka rather than the 2.5 pg indicated in 
Dolezel et al. (Jaroslav Doležel and Bartoš 2005) based on our results obtained with other 
standards. Doležel et al. (J. Doležel, Doleželová, and Novák 1994) estimated 2C DNA 
amount of Glycine max ‘Polanka’ as 2.5 pg using human male leucocytes with 2C = 7.00 
pg. However using Raphanus sativus Saxa at an estimated genome size of 1.11 pg, M. 
truncatula Jemalong (HM101) at an estimated genome size of 1.15 pg and Lycopersicon 
esculentum Stupicke at an estimated genome size 1.96 pg, we found that 2.3 pg was our 
average estimate of genome size for Glycine max Polanka using our methods and the 
same FACSCalibur flow cytometer used to sample all accessions.  
Functional annotation 
Repeat elements were masked using RepeatMasker (Smit, Hubley, and Green 1996) 
with the M. truncatula repeat library. AUGUSTUS (Stanke and Waack 2003) was used to 
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make ab initio gene predictions for each genome assembly with both RNA-Seq 
expression evidence and HM101 homology evidence. RNA-Seq data came from 
sequencing of four diverse accessions, HM034, HM056, HM101 and HM340, performed 
by colleagues in Dr. Robert Stupar’s research group. Reads from HM034, HM056 and 
HM340 were directly mapped to their de novo assemblies using Tophat (Trapnell, 
Pachter, and Salzberg 2009) to generate intron hints for AUGUSTUS. For the remaining 
12 accessions, we mapped the RNA-Seq reads from the closest available accession (one 
of HM034, HM056, HM340 or HM101) to the corresponding assembly and generated 
intron hints. We also transferred HM101 (Mt4.0 reference) annotation to each de novo 
assembly using synteny block (see next section: Comparative genomics analysis) 
information and generated exon hints for AUGUSTUS. Predicted protein sequences were 
scanned for PFAM domains (Pfam-A.hmm) (Finn et al. 2014) using HMMER (Sean R. 
Eddy 2011) and processed using custom scripts that I created. Domain categories were 
then assigned to each protein sequence according to the most significant Pfam hits. 
Among the resulting Pfam domains we curated 133 (Appendix Table 2.2) as being 
associated with transposable elements and grouped these into a large “TE" category. 
NBS-LRR genes were curated using sub-family HMMs (13 TNL subgroups and 22 CNL 
subgroups) built based on previous literature (Ameline-Torregrosa et al. 2008). I also ran 
SPADA (Small Peptide Alignment Discovery Algorithm) (Zhou et al. 2013), as described 
in detail in Chapter 1, on each assembly to refine annotation of 516 CRP gene families. 
Comparative genomics analysis  
Each de novo assembly was first aligned to the Medicago HM101 reference 
sequence (version 4.0) using BLAT (Kent 2002). Unaligned sequences (query sequences 
with no hit to the reference genome) were extracted and BLAT-aligned for a second time 
because it was found that BLAT tends to over-extend gap length whenever it encounters 
an assembly gap (stretches of ‘N’s). The resulting alignments were merged, fixed 
(removing non-syntenic or overlapping alignment blocks), cleaned (removing alignment 
blocks containing assembly gaps) using custom scripts. BLAT Chain/Net tools were then 
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used to obtain a single coverage best alignment net in the target genome (HM101), as 
well as a reciprocal-best alignment net between the two genomes. Finally, genome-wide 
synteny blocks were built for each de novo assembly (against HM101), enabling 
downstream analyses including variant calling, novel sequence identification and 
ortholog detection. 
Synteny-based variant detection and structural variation identification 
Based on the synteny blocks built for each de novo assembly and HM101, I 
identified SNPs (single base mismatches), short insertions and deletions (alignment gaps 
≤ 50 bases), as well as large SVs. As illustrated in Figure 2.2 and in the Results, this 
enabled detection of large deletions (deleted sequence not present anywhere in the target 
genome), insertions (inserted sequence not present anywhere in the query genome), 
translocations (deleted sequence is inserted somewhere else in the genome and present 
only once) and copy number gains and losses (deleted or inserted sequence present 
elsewhere in the genome but belongs to another synteny block - i.e., present more than 
once). Variant calls from 15 accessions were converted to Variant Calling Format (VCF) 
and merged to a single VCF file using Bcftools (H. Li et al. 2009). Custom scripts were 
run to fill in missing genotypes (variants called in one accession but not another) where 
reference-genotype could be concluded according to synteny alignment information.  
Novel sequence identification and Pan-16 genome construction 
A raw set of novel sequences (i.e., sequences present in one or more de novo 
assemblies but absent in HM101) were obtained by subtracting all the aligned regions 
from the entire gap-removed assembly. Low-complexity sequences and tandem 
duplications were then scanned and removed using Dustmasker (Camacho et al. 2009) 
and Tandem Repeat Finder (Benson 1999). The remaining novel sequences were BLAST 
(Altschul et al. 1990) against the NCBI Nonredundant nucleotide (NT) database to 
determine their apparent species of origin, and classified into three categories: plant 
origin (having a best hit in Medicago, soybean, lotus or other plant species), foreign (best 
hit in non-plant species, e.g., endophytic bacteria, eukaryotic, etc.) and unknown (no 
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hits). Foreign sequences were filtered out in subsequent analyses. In order to understand 
the sharing status of novel sequences among different accessions, I ran Para-Mugsy 
(parallel version of MUGSY - the multiple whole genome aligner) (Angiuoli and 
Salzberg 2011) to build a multiple alignment of all novel sequence segments identified in 
15 accessions. The resulting alignments were parsed and analyzed using custom scripts to 
determine how each segment is shared among accessions – e.g., private to one accession 
or shared by multiple accessions. We then constructed a Medicago Pan-16 genome which 
includes the Mt4.0 (HM101) reference as the backbone, as well as all non-redundant 
novel segments identified in the other 15 accessions. We further derived a pan-genome 
size curve and a core-genome size curve by adding one de novo assembly to the pool at a 
time and calculating the size of shared genomic regions (core-genome) and the size of 
total non-redundant sequences (pan-genome). 
Comparison of variants (SNPs, short indels) identified by a reference-mapping 
approach and de novo assembly-based approach 
Sequencing reads were also mapped to the Mt4.0 reference using GSNAP (Wu and 
Nacu 2010). Resulting alignments were converted to a BAM (H. Li et al. 2009) file 
which went through the standard GATK pipeline (DePristo et al. 2011) including 
duplication removal, indel realignment and base recalibration. SNPs and short indels 
were then called using GATK UnifiedGenotyper with default parameters. These 
mapping-based variants were evaluated against our synteny-based variant calls to 
generate a Venn Diagram for each accession, which includes an overlapping set (variants 
called by both approaches), a mapping-only call set (variants called by the GATK 
pipeline but not by the de novo assembly comparison) as well as an assembly-only call 
set. Since insertion/deletion positions are sometimes ambiguous, we left-aligned all indels 
from both approaches using the GATK LeftAlign module prior to the comparison. 
Nevertheless, multiple nucleotide polymorphisms (MNP) could still have different 
representations between the two approaches. As a result, the actual intersection of indels 
called from two approaches is probably underestimated. To see whether the assembly-
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only SNP calls are enriched in more divergent genomic regions, we partitioned the 
genome into 1-kbp windows. For each window we then calculated sequence percent 
identity and the proportion of assembly-only SNPs calls (out of all SNPs called). 
Results 
Sequencing and de novo assembly 
Each accession was sequenced with Illumina HiSeq2000 using a combination of 
short and long insert paired-end libraries with insert sizes of 180 bp and 9 kbp, for an 
average of 120 fold coverage (Appendix Table 2.1), and assembled using the 
ALLPATHS-LG whole genome assembler (see Methods). All fifteen genomes were well 
assembled: approximately 80%-94% of each of the genomes were assembled into 
scaffolds at least 100 kbp long, with scaffold N50 sizes ranging from 268 kbp to 1,653 
kbp, and contig N50 sizes around 20 kbp (Table 2.1). Mate-pair libraries with large insert 
size significantly improved scaffolding, with the longest scaffold size reaching 16 Mbp - 
almost the length of a chromosome arm. Assembled genome sizes ranged from 388 Mbp 
to 428 Mbp, correlating well with the experimentally derived genome size estimates 
(Correlation coefficient = 0.83, P-value = 0.005, Figure 2.3). Gap-removed genome sizes 
are smaller than but comparable to the BAC-based Mt4.0 (HM101) reference genome 
(Table 2.1). About 20% of each assembly were annotated as repeat elements – slightly 
lower than 23% repetitive content in Mt4.0 reference (Table 2.1), an indication that 
repetitive sequences been missed / collapsed in these de novo assemblies to some extent. 
However, these assemblies essentially capture 87-96% of the unique contents in the 
reference genome space, including 90-96% of genic coding regions. As such, the current 
assemblies enabled accurate detection of variation and comparative analyses within genic 
regions.  
Functional annotation, identification of CRPs and NBS-LRRs  
Evidence-guided annotation integrating homology searches, RNA-Seq expression, 
and ab initio prediction yielded comparable numbers of coding genes (60,000 to 67,000) 
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for each of the 15 assemblies (Table 2.2). The number of transposable element (TE)-
related genes identified in the 15 accessions were on average 20% lower than the HM101 
reference – confirming that de novo assemblies have missed or collapsed some repetitive 
sequences. A closer look at the number of different TE categories suggests certain TE 
families were more likely to be missed / collapsed in de novo assemblies than others 
(Appendix Table 2.4), probably reflecting different sequence characteristics (GC content, 
mappability, etc.). Median protein length (TEs excluded) ranged from 218 to 228 amino 
acids – nearly equal to the estimate of 228 amino acids in HM101, an indication that long 
scaffold and contig N50s have helped keep the gene models intact. The quality of the 
annotation was supported by the observation that 77-87% of genes were either supported 
by an HM101 homolog or expressed (as determined by RNA-Seq) (Table 2.2). Large 
gene families such as NBS-LRRs and CRPs generally have consistent numbers of 
members among accessions (Table 2.2, Appendix Table 2.3); however, these gene 
families harbored complicated homology relationships with the accessions differing 
markedly in the size of specific sub-families (Appendix Table 2.5, 2.6). Further analysis 
(see Chapter 3) suggests family-specific expansion / contraction is a frequent 
phenomenon observed in large gene families. 
Comparative analysis 
I was able to align 92%-96% of each assembly with the HM101 reference (Table 
2.3) using custom pipeline (see Methods). I also identified ~300 Mbp of sequences in 
syntenic blocks between each assembly and HM101, where SNPs, short indels and large 
SVs can be confidently determined. Global comparison revealed large syntenic blocks of 
conserved genomic regions as well as poorly aligned regions where structural changes 
frequently take place (Figure 2.4). The analysis suggests that synteny tends to break 
down near centromeric regions, where TE density is high, as well as regions enriched in 
highly variable gene families such as NBS-LRRs (Figure 2.4 and Figure 2.6, “covered 
bases” track). I found that chromosomes 3 and 6 have the highest level of non-
centromeric structural changes (breaks in synteny) across all 15 accessions (Figure 2.4); 
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interestingly, these two chromosomes also harbor the highest number of NBS-LRRs, 
together accounting for 43% of the entire NBS-LRR family. Indeed, while ~80% of non-
TE coding genes (genic regions) are located within conserved synteny regions, a loss of 
synteny between two compared accessions was often observed in regions containing 
either transposable elements (TEs, 53% in synteny blocks versus 47% outside) or rapidly 
evolving gene families such as NBS-LRRs (63% in synteny blocks versus 37% outside). 
It is therefore clear that rapidly evolving gene families, particularly TEs and NBS-LRRs, 
significantly increase local genome fragility and contribute to the overall genome 
architecture. 
Global view of variation (SNPs, short indels, SVs)  
In aligned genomic regions we found extensive variation including SNPs, short 
indels and large SVs. Altogether, I identified between 1.7 million (HM058) and 5.1 
million (HM340) single nucleotide changes as compared to the HM101 reference (Table 
2.4). As expected, SNP density correlates well with divergence from HM101 - with SNP 
bp-1 ranging from 0.63% of HM058 (closest to HM101) to 2.37% of HM340 (most 
distant from HM101). These estimates are much higher than previous reports based only 
on aligning next generation reads to the reference genome sequence. While sequencing 
errors, assembly errors and alignment ambiguities could all lead to elevated SNP rate 
estimates, many of the identified substitutions here are very likely to represent true 
diversity in regions previously overlooked by read-mapping approaches (see Discussion). 
 In addition to SNPs, I identified between 200,000 and 700,000 short insertions and 
deletions (size less than 50 bp), altogether affecting 1.5 - 5.3 Mbp. Large SVs including 
large insertions, deletions, translocations and copy number changes were also identified 
at base pair accuracy using synteny block information (Table 2.4; Figure 2.5). Although 
much rarer in occurrence, these large changes affect many more bases than do smaller 
changes (SNPs and short indels, Table 2.4) do. For example, there are 255k total small 
deletions in HM056 affecting 1.5 Mbp sequences, but 16.5k large deletions affecting 6.3 
Mbp sequences. This is consistent with findings in other systems where large variants 
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typically have greater structural impacts on the genome (Redon et al. 2006; Conrad et al. 
2010). My analysis identified nearly equivalent number of small insertions and deletions, 
which reflects the randomly arising nature of indels and is in strong contrast with 
traditional read mapping-based approach that typically calls more deletions than 
insertions (relative to reference sequence). When it comes to larger variants, however, the 
protocol used here still sees a limited power in detecting large insertions and copy 
number gains (CNG) – as evidenced by the number of large deletions and copy number 
loss (CNL) events being 30-50% higher (Table 2.4). Given that the high-quality BAC-
based Mt4.0 reference is both more complete (8-10% larger) and continuous than the 15 
de novo assemblies, sequences present in the reference but absent in other accessions 
(i.e., large deletions and CNLs) would have a higher chance to be picked up than large 
insertions and CNGs do. 
A total of 7% (HM058) to 22% (HM022) of the entire genome content is affected by 
at least one type of structural changes (Table 2.4). Sequences in these regions are either 
highly divergent (and thus cannot be aligned), or deleted, inverted, duplicated or 
translocated to ectopic genomic locations (Figure 2.5). When using reference-mapping 
variant calling approaches, sequence affected by a simple deletion is simply removed in 
one accession, so this will manifest a sudden drop of read coverage in the deleted area. 
However, in the case of translocation and copy number changes, the actual sequence 
content is still present in the affected genome but at a different genomic position. Short 
read aligners will still try to place reads in these structurally different regions, resulting in 
erroneous SNP calls, which could be misleading for the downstream population genetics 
analysis and association studies. The synteny-based variant calling approach we 
employed, however, restricts SNP calling to syntenic blocks and thus provides a more 
accurate view of true genomic variation (see Discussion for detail).  
Population genetics of identified variants 
Based on the ~7 million SNPs I obtained genome-wide nucleotide diversity estimates 
(θπ = 0.0073 bp-1 and θw = 0.0082 bp-1, Table 2.5), values much higher than the 
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economically important legume Glycine max (θw culticated = 0.0017 bp-1 and θw wild = 0.0023 
bp-1) (Lam2010). Approximately 70% of the SNPs were found in intergenic regions, 
which are also featured by the highest level of nucleotide diversity (θπ = 0.0089 bp-1). 
Diversity was much higher for synonymous than replacement polymorphisms in coding 
regions (Table 2.5). The minor allele frequency (MAF) spectrum also showed higher 
frequencies of rare variants (present in only one accession) for replacement and large 
effect SNPs (lost of start or stop codon, splice site variant, etc.) than other types of 
polymorphisms without an apparent functional impact (Appendix Figure 2.1). These 
findings are consistent with the expectation of stronger purifying selection acting at 
replacement sites, especially large-effect polymorphisms significantly changing the 
protein product (Nielsen 2005). 
Our estimates of nucleotide diversity (θπ = 0.0073 bp-1 based on 13 ingroup 
accessions) were 70% higher than previous results (θπ = 0.0043 bp-1 based on 26 
accessions) (Table 2.5) (Branca et al. 2011). This probably reflects a better estimate of 
the true genomic diversity within M. truncatula for the following reasons: (1) a better 
reference genome (Mt4.0 versus Mt3.0) allows more (potentially divergent) genomic 
regions to be assessed; (2) higher sequencing depth and newer sequencing chemistry 
(jumping libraries) help resolve repetitive (and highly variable) genomic regions and 
gene families; (3) directly comparing de novo assembly to a reference allows access to 
more repetitive and highly divergent genomic regions (down to 70% percent identity), 
which is not possible by read mapping-based approach and short read aligners (typically 
requiring >90% percent identity of a read to the reference) (see Discussion for detail). 
Sliding window analysis suggests that SNP-based nucleotide diversity (θπ) was 
generally higher at centromeric regions than at telomeric regions, with the exception that 
certain highly variable gene families such as NBS-LRRs also significantly elevate 
diversity level (Figure 2.6). While nucleotide diversity was negatively correlated with 
gene density (r = -0.212, P = 6.58e-47), it is positively correlated with TE density (r = 
0.328, P = 0) and NBS-LRR density (r = 0.282, P = 0), and marginally with CRP density 
(r = 0.089, P = 0), confirming the high diversity of these large gene families (Appendix 
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Table 2.1).  We also calculated a diversity statistic for short indels and large structural 
variation (Figure 2.6, Pi[InDel] and Pi[SV] tracks). Interestingly, these two statistics 
show trends very similar with SNP-based nucleotide diversity estimate, an indication of 
common local ancestries of different types of variation. Also, the diversity of short indels 
and SVs are negatively correlated with gene density and positively correlated with TE 
density and NBS-LRR density (Appendix Table 2.7), confirming the fragility and rapid 
evolution of these gene families. 
Novel sequences identification and Pan-16 genome construction 
During the comparison, we found extensive “novel” sequence in the 15 de novo 
assemblies that could not be aligned to the Mt4.0 reference even with a relaxed alignment 
stringency (70%-80% sequence percent identity). These sequences often exist in the form 
of novel insertions or complex substitutions, and sometimes as separate scaffolds. After 
filtering potential contaminant (foreign) sequences, we identified 9 - 22 Mbp novel 
segments (longer than 50 bp) in each of the 15 de novo assemblies (Table 2.3). In order to 
understand how these novel sequences are shared among 15 accessions, we made a 
multiple sequence alignment of all the novel segments and determined the presence and 
absence of each segment in each genome. Out of the total 63 Mbp non-redundant novel 
sequences identified, 47% are present in at least 2 accessions, with the remaining 53% 
being specific to a single accession (Figure 2.7A). The observation that sequencing 15 
additional genomes adds at least 16% more unique content to the reference genome, and 
that nearly half of the novel sequences are found in more than one other accession, both 
indicate that having a single reference has seriously limited our understanding of the 
content of population gene pool and the level of genomic variation in natural Medicago 
populations. 
I then obtained a size curve for both the pan-genome and the core-genome (Figure 
2.7B), by randomly adding one genome to the population pool at a time. The core-
genome size curve first drops quickly but then reaches a plateau after 10 accessions are 
added. Approximately 270 Mbp sequences were shared among all 16 accessions 
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including the Mt4.0 reference, representing most of the conserved coding and regulatory 
regions that presumably play vital house-keeping functions. On the other hand, another 
~180 Mbp sequences were missing from at least one accessions (“dispensable”), 
reflecting the dynamic nature of genome content and prevalence of insertion / deletion, 
copy number variation and other structural changes in the Medicago populations. 
Similarly, the pan-genome size curve first sees steady increases each time when a new 
genome was added to the pool, and then reaches a stable value of approximately 450 Mbp 
(Figure 2.7B). Thus, our analysis of 16 M. truncatula accessions already suggests a 
“restricted” nature of the Medicago pan-genome: sequencing additional genomes will 
expand the current pan-genome by bringing in more (but minimal) novel sequences and 
variation. 
Among the novel sequences identified, 1.3 – 2.5 Mbp per accession were predicted 
to be protein coding (Table 2.3). Enriched in these novel coding genes are TE-related 
genes and NBS-LRRs: while on average less than 2% of non-TE genes were identified as 
absent from the reference accession, as many as 2.8% of TEs and 6% of NBS-LRRs 
contribute to the “novel” gene pool (Appendix Figure 2.2). Interestingly, these gene 
families are also among the most poorly characterized genomic regions in our earlier 
discussion (“Results – Comparative analysis” section, Figure 2.4). In fact, based on the 
synteny alignments built for each de novo assembly we were able to cover 75% (31,048) 
of all non-TE reference gene models including 77% (554) of NCRs (≥ 80% coding 
regions in ≥ 10 accessions), while only 44% (5,418)  TEs and 48% (414) NBS-LRRs 
were covered using the same criteria. Enrichment of these complex gene families in novel 
gene pool partially explains their poor coverage by synteny alignment. The rapid 
evolving nature and turnover of these genes greatly accelerate their divergence within the 
population, thus preventing both read mapping and syntenic anchoring. That said, the 
total number of NBS-LRRs predicted in each de novo assembly did not differ 
significantly from the reference annotation, indicating that instead of being missed by our 
assembly, these NBS-LRRs most likely were captured and assembled to relatively short 
and isolated contigs that could not be anchored to reference chromosomes. 
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Discussion 
De novo assembly and comparative analysis enables exploration of both 
repetitive and highly divergent genomic regions that were previously overlooked 
by mapping-based strategies 
My results show that SNP-based nucleotide diversity has been seriously 
underestimated by as much as 70%, in previous read mapping-based resequencing 
studies. This conclusion is explained by an improved reference genome (Mt4.0), higher 
sequencing depths, better sequencing chemistries, as well as a comparative variant 
discovery approach based on directly comparing de novo assemblies. It becomes essential 
then, to know better the gains and losses that our “synteny-based” variant calling 
provides versus the traditional “reference mapping-based” approach. To answer this 
question, we also ran the same set of original sequence reads through a read mapping and 
variant detection pipeline for selected accessions, and came up with a second set of 
variant calls (see Methods). While 75%-80% of the identified SNPs overlap between 
methods, a considerable fraction of variants (~20%) are only called by one approach 
(Figure 2.8A, Appendix Figure 2.4). We found that SNPs called only by mapping-based 
approach (“mapping-only” calls) are highly enriched in SV regions as determined by our 
assembly comparison: 75% mapping-only SNP calls were found in SV regions which 
account for ~15% of the entire genome. In other words, short read aligners have a 
tendency to place reads regardless of the genome context and therefore tend to make 
erroneous variant calls (see Figure 2.9 for illustration). Synteny-based comparisons, by 
contrast, are able to distinguish structural changes (translocation, etc.) from continuous 
alignments using synteny information, and know where SNPs should be called and where 
not. Indeed, further examination reveals that compared to the overlapping (validated) call 
set, these mapping-only SNP calls receive much lower read-depth support (typically just 
two reads, Figure 2.8C), very likely arising through read cross-mapping. I also 
investigated variants called by the synteny-based approach but missed by the mapping-
based approach (i.e., “synteny-only” calls), and found that they are enriched in highly 
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polymorphic genomic regions (Figure 2.8D). As sequence divergence (SNP density) goes 
up, the mapping-based approach calls fewer and fewer SNPs while the proportion of 
synteny-only calls dramatically increases. In fact, 100% of SNP calls are made by the 
synteny-based approach alone when sequence similarity drops below 92%, consistent 
with the initial aligning parameters set for the short read aligner (a maximum of 8 
mismatches per 100-bp read). Simply increasing the number of allowed mismatches does 
not solve the problem and only leads to more false positive SNP calls due to cross 
mapping, as evidenced by the enrichment of false positive SNP calls in SV regions. 
Moreover, the mapping-based approach generates considerable number of heterozygous 
calls (13-17% of all calls), most of which are not validated by assembly-comparison 
(Figure 2.8E) and are also enriched in highly polymorphic regions (Figure 2.8F) - a sign 
that allowing 8 mismatches is already creating serious cross-mapping issues. Such highly 
polymorphic regions and repetitive elements together lead to insurmountable difficulties 
for read mapping software and can only be effectively addressed by creating de novo 
assemblies for direct comparison. Reads are either discarded by aligners due to non-
unique mapping or high number of mismatches and/or gaps, resulting in regions of low or 
zero (effective) coverage, or cross-mapped and mis-placed in structurally different 
regions if allowing too many mismatches (Figure 2.9). Synteny-based approach, on the 
other hand, accurately calls variants in such regions as long as syntenic alignments 
contiguously span the area. Future resequencing efforts with long read technology will be 
even more powerful in further resolving these repetitive and structurally different regions 
and should greatly improve our understanding of natural variation. 
Synteny comparison offers accurate detection of both small and large variants 
Beyond improved accuracy and precision in SNP discovery, the assembly 
comparison-based approach also enables better detection and characterization of insertion 
/ deletion polymorphisms and complex structural changes generally. Resequencing 
studies typically tend to discover more deletions than insertions (relative to the reference) 
(Massouras et al. 2012). While there is no biological reason to expect more deletions than 
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insertions for a random sample, this ascertainment bias can largely be explained by the 
inherent limitation of short read aligners – a read with a deletion is easier to map than a 
read with an insertion. Directly comparing two assemblies, however, does not have this 
limitation and as a result, leads to a much more symmetrical size spectrum for small 
insertions and deletions (Appendix Figure 2.3). Insertion events longer than 10-bp are 
virtually invisible to read mapping-based approach, but can be effectively recovered by 
assembly comparison (Appendix Figure 2.3).  
Nonetheless, ascertainment bias still exists for our assembly-based approach in the 
case of larger variants (≥ 50bp). The number of large deletions and copy number loss 
(CNL) events is on average 30-50% higher than that of large insertions and copy number 
gain (CNG) events (Table 2.4). This is not surprising given that the de novo assemblies 
are less complete (8-10% smaller) and more fragmented than the high-quality HM101 
reference, and so many large insertion and CNG events are not captured due to 
insufficient synteny evidence (flanking sequence support) in a fragmented assembly. 
Improvement in sequencing and assembly technologies (especially longer reads) should 
lead to more complete and contiguous de novo assembles, enabling better detection and 
characterization of structural variants of all types. 
While it is inherently difficult to detect large structural variants (from a few hundred 
bp to several thousand bp) with direct read mapping due to their relatively short read 
length (typically 100-bp), researchers have developed alternative approaches to detect 
structural variation by making use of special traces left in and around structurally 
changed regions during read mapping. Some of these algorithms compare empirical 
Depth-Of-Coverage (DOC) information with genome-wide average, identify regions with 
sudden drop or gain of read coverage and predict Copy Number Variation (CNV) events 
(Alkan et al. 2009; Yoon et al. 2009; Chiang et al. 2009). Other algorithms take 
advantage of the Paired-End Mapping (PEM) signatures left by inappropriately placed 
read pairs (soft clipped, orphan reads, abnormal insert size, etc.) around structurally 
altered regions, and then work to recover the actual break point of each SV (Korbel et al. 
2009; Chen et al. 2009; Hormozdiari et al. 2009; Lee et al. 2009). While the PEM-based 
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approach is good at pinpointing SV breakpoints, the DOC-based approach is good at 
capturing large unbalanced sequence content changes such as CNVs and PAVs 
(Medvedev, Stanciu, and Brudno 2009; Alkan, Coe, and Eichler 2011). However, they 
both have their limitations. The DOC-based approach relies on a Poisson distribution of 
the read-depth signal, which is hard to satisfy in practice, being sensitive to local 
sequence characteristics such as GC content and repetitiveness (Bailey 2002). This makes 
DOC-based approaches less accurate in predicting CNVs of smaller size and blind to 
balanced sequence changes such as translocations and inversions. The PEM-based 
approach, on the other hand, is dependent on the insert size distribution, requiring a fixed 
cutoff of mapped insert size to be classified as “discordant”, and also does not work in 
repetitive regions. Moreover, both DOC-based and PEM-based approaches absolutely 
rely on the correct mapping of reads in and around the SVs in the first place. They both 
fail where insufficient evidence of paired-end signatures can be found, such as highly 
polymorphic regions or repeat-rich regions. 
Fortunately, these difficulties can all be bypassed by directly comparing a de novo 
assembly to the reference and calling variants using synteny alignment information. Both 
unbalanced variants (insertion, deletion, CNG, CNL) and balanced variants 
(translocation, inversion) can be detected and characterized with exact breakpoints 
identified at base-pair level. This analysis highlights the importance of comparative 
genomics using de novo assemblies and elevates our understanding of natural genomic 
variation to a completely new level. 
Chromosomal-scale translocation revealed 
Kamphuis et al. reported an aberrant rearrangement between Medicago linkage 
groups 4 and 8 (LG4 & LG8) in the reference accession A17 (Kamphuis et al. 2007). 
Based on synteny alignment against A17, we were able to confirm this large structural 
variation event comparing A17 with at least three accessions (HM004, HM034 and 
HM185, Figure 2.10). In addition, the exact breakpoints of the translocation were 
pinpointed to a single region on chromosome 4 and three regions on chromosome 8 
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(Figure 2.10 for illustration, Appendix Figures 2.5 and 2.6 for exact synteny 
relationship). Interestingly, each of the four breakpoints involves a gap (i.e., ‘N’s) in the 
reference (Mt4.0), with three 100 bp gaps and one 7.5 kbp gap - an indication that the 
regions in and around the rearrangement breakpoints are structurally unstable and 
difficult to assemble even using a BAC-by-BAC approach. We found numerous 
transposable element genes near the breakpoints, including a reverse transcriptase, a 
GAG-pre integrase and a cluster of 6 transferases near breakpoint 1 (Appendix Figure 
2.7A), two helicases around breakpoint 2 (Appendix Figure 2.6B), two retrotransposons 
(UBN2) and two reverse transcriptases around breakpoint 3, and a MULE transposase 
right next to breakpoint 4 (Appendix Figure 2.6C). Interestingly, a cluster of at least 10 
CC-NBS-LRRs was found both upstream and downstream breakpoint 2 (Appendix 
Figure 2.7B), and two CC-NBS-LRRs were also found right next to breakpoint 3, 
probably indicating an involvement of these variable gene families in shaping the overall 
genome structure. This translocation is mostly likely private to the reference A17 
accession or clade, since we didn’t find even one accession sharing the same haplotype 
structure with A17. In addition to the translocation, we noticed two large stretches of 
novel sequences (1.15 Mbp and 430 Kbp) downstream the translocation breakpoints on 
chromosome 4 and 8 that could not align anywhere in the reference space (Figure 2.10 
red segments), which is potentially a deletion in A17 as the result of the chromosomal 
rearrangement. Sequencing additional close relatives of A17 may reveal the origin and 
history of this rearrangement. 
Conclusion 
In this study I built high quality de novo assemblies and systematically characterized 
natural variation in 15 M. truncatula accessions. This allowed me to detect novel genetic 
variation that would not have been found by mapping reads to a single reference. This 
analysis leads to a within-species diversity estimate much higher than previous mapping-
based resequencing efforts, even using a smaller sample size. While this could be 
partially explained by a more complete reference genome and newer sequencing 
  54 
chemistry in current study, my results clearly demonstrate that de novo assembly-based 
comparison is both more accurate and precise than mapping-based variant calling in 
exploring variation in repetitive and highly divergent regions. For the first time in plants, 
I was able to systematically identify and characterize different types of SVs using a 
synteny-based approach. My analysis revealed extensive structural variation in natural 
Medicago populations, exerting a larger impact on the overall genome architecture and 
population gene pool than smaller changes such as SNPs and short indels. Based on 
genome-wide synteny alignments against the reference (Mt4.0), I built a Medicago Pan-
16 genome that considerably expands the reference space. Pan-genome analysis suggests 
a “restricted” pan-genome and core-genome size curve, both beginning to level off when 
ten or more accessions become sequenced. Improving existing assemblies and 
sequencing additional accessions may further reveal allelic variation and expand the gene 
pool within the population. 
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Table 2.1. Assembly statistics. 
 Total Span Total Bases 
Scaffold Stats Contig Stats Repeat Elements 
 
Number N50 Median Max Number N50 Median Max Bases Percent 
HM101 413,771,487 389,019,804 
        
88,488,168 22.75 
HM058 409,729,257 355,004,629 4,349 374,919 8,122 3,222,558 27,646 18,510 4,590 350,560 66,415,620 18.71 
HM125 406,998,713 371,005,289 3,666 517,348 3,690 6,709,429 22,291 28,123 5,144 417,578 77,949,143 21.01 
HM056 406,705,336 362,971,816 3,486 511,115 6,755 5,985,141 26,820 19,283 5,305 230,607 71,793,730 19.78 
HM129 398,468,296 367,625,895 3,213 523,031 4,777 5,629,000 21,025 28,693 5,437 303,023 74,929,621 20.38 
HM060 403,209,823 363,308,695 3,634 452,558 5,845 3,832,561 22,495 25,479 5,026 396,295 72,075,459 19.84 
HM095 410,354,770 367,894,112 3,711 526,756 5,178 4,466,334 24,666 25,656 4,285 323,240 73,927,610 20.09 
HM185 428,228,061 367,670,036 3,335 1,653,161 3,289 16,133,123 24,135 25,123 4,839 295,986 75,517,964 20.54 
HM034 396,665,787 362,786,782 3,267 471,390 4,628 6,140,737 21,662 26,724 5,268 374,291 71,953,536 19.83 
HM004 399,385,294 361,118,835 3,494 620,396 3,532 9,290,596 23,574 23,631 5,000 311,906 70,329,693 19.48 
HM050 406,245,560 366,441,111 3,234 855,678 3,170 8,622,067 23,170 25,626 5,027 349,806 74,093,668 20.22 
HM023 403,142,311 361,243,464 3,728 421,953 7,979 5,130,354 22,754 24,359 5,087 327,601 69,990,997 19.38 
HM010 403,887,869 365,935,435 3,159 522,263 6,832 6,544,913 23,676 23,780 5,285 277,285 73,899,843 20.19 
HM022 374,674,840 343,656,937 2,565 694,957 5,305 8,809,216 20,662 21,883 5,849 309,202 64,940,061 18.90 
HM324 421,810,942 343,081,677 7,057 267,849 6,839 4,503,894 41,520 9,236 3,031 201,165 64,671,095 18.85 
HM340 388,188,365 357,565,722 3,890 674,544 2,021 7,121,670 22,470 24,102 5,186 297,747 71,150,565 19.90 
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Table 2.2. Functional annotation statistics. 
 # Total 
Genes 
TE non-TE NBS-
LRR 
CRP@ Median Prot. 
Len.* 
RNA-seq 
(%)# 
Homology 
(%)& 
RNA-seq + 
Homology (%) 
HM101 67102 12312 54790 860 1428 228 39.6 - 39.6 
HM058 64146 9540 54606 800 1280 222 - 85.2 85.2 
HM056 65691 10379 55312 811 1304 220 36.4 84.9 86.9 
HM125 67346 11175 56171 781 1280 218 - 84.4 84.4 
HM129 65607 10455 55152 818 1278 222 - 83.6 83.6 
HM034 64612 9958 54654 774 1266 222 36.0 83.1 85.2 
HM095 65524 10197 55327 823 1283 222 - 82.8 82.8 
HM060 64648 9967 54681 799 1272 223 - 83.7 83.7 
HM185 65921 10666 55255 822 1274 222 - 83.4 83.4 
HM004 64374 9680 54694 797 1278 224 - 82.8 82.8 
HM050 65691 10282 55409 828 1289 224 - 82.6 82.6 
HM023 64310 9661 54649 797 1281 222 - 83.2 83.2 
HM010 65373 10339 55034 834 1304 223 - 83.2 83.2 
HM022 59882 8193 51689 704 1295 227 - 78.6 78.6 
HM340 64587 9387 55200 784 1287 228 36.1 75.1 77.6 
HM324 60236 7751 52485 747 1213 221 - 76.6 76.6 
@CRP: Cysteine rich protein family 
*Median protein length (number of amino acids) was estimated using non-TE coding genes; 
#RNA-Seq was done for four accessions using both un-inoculated root tissue and nodule; number indicates percentage of total predicted transcripts 
with FPKM > 0; 
&Number indicates percentage of total predicted transcripts with at least one Mt4.0 ortholog (either syntenic ortholog or RBH-based homolog). 
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Table 2.3. Assembly comparison (with Mt4.0) statistics and novel sequences identified in 15 M. truncatula accessions 
 Total Bases Repetitive Alignable to 
HM101 
Bases in 
Synteny  
Novel Sequences* Novel Coding Seq 
HM058 355,004,629 66,415,620 343,325,053 323,600,625 9,024,826 2.50% 1,297,448 14.40% 
HM125 371,005,289 77,949,143 357,808,394 327,976,297 9,863,489 2.70% 1,386,659 14.10% 
HM056 362,971,816 71,793,730 350,554,159 326,377,315 9,377,865 2.60% 1,368,844 14.60% 
HM129 367,625,895 74,929,621 351,879,700 320,623,943 11,755,160 3.20% 1,631,646 13.90% 
HM060 363,308,695 72,075,459 347,211,386 317,763,091 12,044,190 3.30% 1,690,709 14.00% 
HM095 367,894,112 73,927,610 351,219,964 317,035,668 12,460,933 3.40% 1,709,362 13.70% 
HM185 367,670,036 75,517,964 351,105,536 317,771,859 12,390,758 3.40% 1,729,628 14.00% 
HM034 362,786,782 71,953,536 346,005,399 317,021,576 12,433,286 3.40% 1,727,260 13.90% 
HM004 361,118,835 70,329,693 344,257,187 315,304,988 12,721,129 3.50% 1,979,711 15.60% 
HM050 366,441,111 74,093,668 349,114,197 317,140,191 13,022,686 3.60% 2,157,804 16.60% 
HM023 361,243,464 69,990,997 344,455,479 315,834,571 12,376,960 3.40% 1,687,239 13.60% 
HM010 365,935,435 73,899,843 348,722,480 316,833,225 12,639,855 3.50% 1,726,239 13.70% 
HM022 343,656,937 64,940,061 315,921,590 275,649,889 19,732,777 5.70% 2,099,922 10.60% 
HM324 343,081,677 64,671,095 312,883,637 266,427,488 21,757,962 6.30% 2,449,025 11.30% 
HM340 357,565,722 71,150,565 326,264,086 279,190,368 20,778,471 5.80% 2,319,870 11.20% 
*Novel sequences are segments not present in Mt4.0 (HM101) reference. 
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Table 2.4. Variants identified in 15 M. truncatula accessions by count (A) and affected base pairs (B). 
(A) 
 SNP# SNP 
Density 
Small Ins Small Del Large Ins Large Del CNG* CNL$ Translocation 
HM058 1,699,815 .0057 229,566 236,818 11,716 15,100 23,266 26,208  2,720 
HM056 1,858,188 .0061 247,352 255,007 12,390 15,791 26,366 27,388  3,153 
HM125 2,075,142 .0067 272,820 281,889 14,317 17,469 29,919 30,885  3,513 
HM129 2,709,716 .0091 353,523 364,363 18,667 23,139 37,076 38,803  4,953 
HM034 2,821,493 .0095 368,749 377,083 19,835 25,989 37,517 39,421  5,581 
HM095 2,722,049 .0093 356,148 365,297 18,427 22,636 36,837 39,150  5,194 
HM060 2,795,046 .0094 363,601 374,109 18,602 23,586 36,516 39,458  4,942 
HM185 2,670,644 .0093 348,954 359,196 18,472 22,810 36,206 38,239  4,788 
HM004 2,860,239 .0097 372,819 382,431 18,906 24,343 37,187 40,737  5,041 
HM050 2,868,988 .0097 372,123 382,998 19,498 24,529 38,145 41,014  5,225 
HM023 2,885,692 .0098 375,818 385,247 19,709 26,130 37,571 39,726  5,711 
HM010 2,906,704 .0099 377,205 386,894 20,236 26,458 39,084 40,045  6,027 
HM022 5,069,762 .0206 733,635 736,313 45,302 66,834 80,780 88,265 12,456 
HM340 5,072,373 .0206 723,866 735,113 45,992 64,314 82,122 86,748 12,788 
HM324 4,984,659 .0216 731,037 734,307 41,946 67,122 76,984 87,641 12,666 
#Numbers listed here are all synteny-based variant calls; 
*CNG: Copy number gain; 
$CNL: Copy number loss. 
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(B) 
 SNP SNP 
Density 
Small Ins Small Del Large Ins Large Del CNG CNL Translocation 
HM058 1,699,815 .0057 1,472,729 1,433,967  2,907,955  4,793,101  6,444,318 20,368,937  3,562,521 
HM056 1,858,188 .0061 1,604,545 1,557,103  2,981,372  4,857,991  8,113,896 21,380,128  4,226,924 
HM125 2,075,142 .0067 1,748,580 1,717,576  3,496,909  5,635,199 10,027,202 24,014,458  4,944,633 
HM129 2,709,716 .0091 2,208,085 2,241,253  4,614,069  7,342,439 13,060,326 28,844,685  6,815,118 
HM034 2,821,493 .0095 2,363,055 2,356,532  4,882,635  8,945,373 12,472,627 27,903,777  7,324,491 
HM095 2,722,049 .0093 2,234,135 2,242,821  4,473,529  7,056,774 12,803,351 28,792,835  7,798,090 
HM060 2,795,046 .0094 2,285,418 2,312,236  4,494,901  7,367,260 11,875,765 28,864,192  6,531,081 
HM185 2,670,644 .0093 2,210,653 2,216,582  4,688,974  7,036,603 11,944,244 28,452,857  6,883,387 
HM004 2,860,239 .0097 2,350,976 2,375,956  4,564,540  7,826,327 11,743,812 29,647,325  6,444,519 
HM050 2,868,988 .0097 2,350,028 2,373,850  4,705,884  7,586,259 12,515,726 29,768,759  6,715,431 
HM023 2,885,692 .0098 2,425,521 2,405,538  4,771,137  8,801,487 11,836,264 28,012,528  7,383,912 
HM010 2,906,704 .0099 2,429,096 2,423,439  4,925,567  8,920,031 12,921,565 28,068,159  7,407,099 
HM022 5,069,762 .0206 5,132,433 5,133,963 10,211,293 21,744,266 25,079,221 50,472,526 13,098,504 
HM340 5,072,373 .0206 5,079,289 5,107,633 10,466,002 20,071,674 27,438,010 49,833,972 14,307,541 
HM324 4,984,659 .0216 5,077,977 5,325,368  9,070,313 20,128,282 22,585,126 46,987,452 13,245,864 
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Table 2.5. Coverage and diversity statistics by nucleotide class. 
 
Covered bases (bp)# Total bases (%) Polymorphic sites π bp-1 θw bp-1 
Total 279,689,505 - 7,043,505 0.0073 0.0082 
Coding 49,106,309 0.18 897,243 0.0052 0.0060 
Synonymous 7,219,248 0.03 190,416 0.0076 0.0086 
Replacement 31,776,906 0.11 489,490 0.0044 0.0050 
Introns 63,144,752 0.23 1,148,781 0.0053 0.0059 
UTR 5' 3,505,093 0.01 43,689 0.0036 0.0040 
UTR 3' 6,241,117 0.02 86,575 0.0040 0.0045 
Intergenic 157,692,234 0.56 4,867,217 0.0089 0.0100 
#Covered bases represent reference genomic regions covered by syntenic alignments in at least 10 
(out of 13) in-group accessions. 
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Figure 2.1. Phylogeny of selected Medicago accessions with their countries of 
origin.  
Maximum likelihood tree built using 15,000 SNPs randomly sampled from all 
chromosome 5 SNPs called by the Medicago Hapmap project. Nodes with ML bootstrap 
support of more than 80% are indicated with filled rectangles. Red Rectangles: 15 
accessions with de novo assemblies described in this thesis. Green Rectangles: 4 
accessions with RNA-Seq data. 
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Figure 2.2. Illustration of synteny-based structural variant detection. 
 
 
  
  63 
 
Figure 2.3. Correlation of assembled genome sizes (ALLPATHS) and 
fluorometry-based genome size estimates in nine M. truncatula accessions. 
correlation coefficient = 0.834  p−value = 0.0052
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Figure 2.4. Heatmap showing percent covered by synteny alignment for each 100kb window in 15 de novo M. 
truncatula assemblies. 
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Figure 2.5. Illustration of different types of structural variants.  
(A) 6-kbp deletion removing a transposable element (TE) in HM034 (relatively to 
HM101); (B) 6-kbp insertion adding a novel gene (cullin) in HM185; (C) 17-kbp 
translocation between chromosomes 5 and 8 involving a TE plus a nearby gene in 
HM034; (D) 20-kbp inversion followed by partial deletion involving several coding 
genes in HM129.  
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Figure 2.6. Sliding window analyses on chromosome 5 showing reference gap 
position, gene density of different categories (non-TE, TE, NBS-LRR, CRP), 
covered bases (bases covered by synteny blocks in at least 10 out 13 
accessions), and nucleotide diversity (θπ) for SNPs, short InDels (< 50bp) and 
large SVs (>= 50bp). 
Nucleotide diversity (θπ) estimates were calculated using only 13 “ingroup” M. 
truncatula accessions that are close to each other and form a tight clade in phylogeny. 
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Figure 2.7. Novel sequences (absent in HM101) identified in 15 M. truncatula accessions (A) and the Pan-16 genome 
size curve (B). 
The pan-genome size curve and core-genome size curve were derived by adding one de novo assembly to the pool at a time and calculating the 
size of shared genomic regions (core-genome, ‘x’ in the figure) and the size of total non-redundant sequences (pan-genome, ‘o’ in the figure). This 
process is repeated 8 times by shuffling the order of accessions. 
0
2
4
6
8
1(accession−specific) 2 3 4 5 6 7 8 9 10 11 12 13 14 15
# Sharing Accession
Se
qu
en
ce
s (
M
bp
)
Accession−Specific
HM058
HM056
HM125
HM129
HM034
HM095
HM060
HM185
HM004
HM050
HM023
HM010
HM022
HM340
HM324
0
10
0
20
0
30
0
40
0
4 8 12 16
# Genomes Sequenced
Ge
no
m
e 
siz
e 
(M
bp
)
Pan−genome
Core−genome
A B
  68 
 
Figure 2.8. Comparison and characterization of SNP calling in HM010 from 
two different approaches. 
(A) Venn-diagram showing overlap of mapping-based SNP call set and synteny-based 
call set; (B) Distribution of mapping-only SNPs in different genomic classes (outer ring) 
and genome-wide distribution of different genomic classes (inner piechart); (C) 
Distribution of read-depth support for “reference mapping-only” SNP calls and SNPs 
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called by both approaches (reference mapping + synteny comparison); (D) Proportion of 
synteny-only SNP calls binned by different sequence identity classes; (E) Proportion of 
heterozygous and homozygous SNP calls (mapping-based) validated by assembly-based 
approach; (F) Proportion of heterozygous SNP calls (out of all mapping-based calls) 
binned by different sequence identity classes. See Appendix Figures 2.4A and 2.4B for 
illustrations in two other accessions (HM004 and HM023). 
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Figure 2.9. Illustration of SNPs called differently by two approaches. 
(A) SNPs are called by both approaches (reference mapping-based and synteny-based) in 
most conserved genomic regions; (B) in repetitive regions, SNPs are only called by 
synteny-based approach and missed by mapping-based approach due to insufficient 
uniquely-mapped reads; (C) in structurally affected (deleted) regions SNPs are 
INCORRECTLY called by reference mapping-based approach due to cross-mapping of 
paralogous reads; (D) in highly divergent (i.e., high SNP density) regions SNPs are only 
called by synteny-based approach and missed by mapping-based approach due to too 
many mismatches in read alignment. 
“Mappability” track (also known as “uniqueness”) provides a measure of how often the 
sequence (60mer) found at the particular location will align within the whole genome 
with up to 2 mismatches (e.g., mappability of 1 means unique mapping and mappability 
of 0.5 means there are two copies of the sequence in the genome). “Coverage” track 
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shows coverage of HM125 reads mapped to HM101 reference. “Mapping SNP” track 
shows locations of SNPs called by read mapping and GATK-UnifiedGenotyper. 
“Synteny SNP” track shows locations of SNPs based on synteny comparison. “SNP 
density” track shows histogram of SNP density (number of synteny-based SNP calls per 
1,000 bp window). 
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Figure 2.10. Schematic illustration of the rearrangement between 
chromosomes 4 and 8 in A17. 
Green segments indicate chromosome 4 ancestry while blue segments indicate 
chromosome 8 ancestry (assuming A17 is the ancestor). Red segments indicate novel 
sequences (i.e., not present in the A17 reference). Breakpoint 1 (br1) is pinpointed to a 
104 bp region (chr4:39,021,788-39,021,891) and includes a 100 bp gap. Breakpoint 2 
(br2) is pinpointed to a 7,665 bp region (chr8:33,996,308-34,003,972) and includes a 
7,663 bp gap. Breakpoint 3 (br3) is pinpointed to a 708 bp region (chr8: 34,107,285-
34,107,992) and includes a 100 bp gap. Breakpoint 4 is pinpointed to a 277 bp region 
(chr8:34,275,249-34,275,525) and includes a 100 bp gap)  
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Chapter 3. Comparing multiple Medicago assemblies enable 
analysis of large gene families on a genome scale 
Medicago truncatula is a model for investigating legume genetics and the evolution 
of legume-rhizobia symbiosis. Over the past two decades, two large gene families in M. 
truncatula, the nucleotide-binding site leucine-rich repeat (NBS-LRR) family and the 
nodule-specific, cysteine-rich (NCR) gene family, have received considerable attention 
due to their involvement in disease resistance and nodulation, large family size, and high 
nucleotide and copy number diversity. Previous studies using whole-genome sequence 
data to identify sequence polymorphisms (SNPs and short Insertion / Deletions; indels) 
relied on mapping short reads to a single reference genome. However, limitations of read-
mapping approaches have hindered variant detection and characterization in both highly 
divergent and repeat-rich regions. As a result, studies of these large gene families are also 
hindered due to high sequence similarity among family members and high divergence 
among accessions. In the present study, I constructed high-quality de novo assemblies for 
15 M. truncatula accessions. This allowed me to detect novel genetic variation that would 
not have been found by mapping reads to a single reference. Evidence-based annotation 
of the 15 de novo assemblies revealed that more than half of reference gene models were 
structurally different (lower than 60% sequence similarity) in at least one other accession. 
Not surprisingly, the NBS-LRR gene family harbors by far the highest level of nucleotide 
diversity, large effect single nucleotide changes, protein diversity and presence / absence 
variation (levels comparable with transposable elements), consistent with the rapidly 
evolving dynamics of disease resistance phenotypes. On the other hand, the one- or two-
exon NCR family is less involved in gene structural changes but more frequently affected 
by copy number variation including both gains and losses in family members. 
Characterization of deletion and tandem duplication events in the NBS-LRR and NCR 
gene families suggests accession-specific subfamily expansion / contraction patterns, 
most of which were supported by PacBio long reads. This work illustrates the value of 
multiple de novo assemblies and the strength of comparative genomics in exploring and 
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characterizing novel genetic variation within a population. This work provides insights in 
understanding the impact of structural variants (SVs) on genome architecture and large 
gene families underlying important traits.  
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Introduction 
Legumes comprise a diverse and ecologically significant plant family that serves as 
the second most important crop family in the world (P. H. Graham and Vance 2003). As 
a cool season legume, Medicago truncatula is closely related to many important crops 
such as alfalfa (Medicago sativa), red and white clover (Trifolium pratense and T. 
repens), pea (Pisum sativum), chickpea (Cicer arietinum), Lotus japonicus as well as 
soybean (Glycine max) and common bean (Phaseolus vulgaris) (Lavin, Herendeen, and 
Wojciechowski 2005; Nevin Dale Young and Udvardi 2009). M. truncatula has been 
chosen as a model for studying legume biology due to its small genome size, simple 
diploid genetics, self-fertility, short generation time, amenability to genetic 
transformation and large collections of diverse ecotypes (Ronfort et al. 2006; Tadege et 
al. 2008; Nevin Dale Young and Udvardi 2009). Research interests on M. truncatula have 
focused on its symbiotic relationship with rhizobia and arbuscular mycorrhizae, root 
development, secondary metabolism and disease resistance (Oldroyd and Downie 2008; 
Nevin Dale Young and Udvardi 2009). Over the past two decades, two large gene 
families in M. truncatula, the nucleotide-binding site leucine-rich repeat (NBS-LRR) 
family and the nodule-specific, cysteine-rich (NCR) gene family, have received 
considerable attention due to their involvement in disease resistance and nodulation.  
The majority of disease resistance genes in plants encode nucleotide-binding site 
leucine-rich repeat (NBS-LRR) proteins. Plant NBS-LRR proteins (also called NB-LRR 
or NB-ARC-LRR proteins) are involved in the detection of diverse pathogens including 
bacteria, viruses, fungi, nematodes, insects and oomycetes (Ellis, Dodds, and Pryor 2000; 
Belkhadir, Subramaniam, and Dangl 2004; Jones and Takemoto 2004). This large, 
abundant gene family is encoded by hundreds of diverse genes per genome and can be 
subdivided into two subgroups based on sequence identity that precede the NBS domain: 
the TIR-NBS-LRR (TNL) proteins that contain a Toll-like domain, and CC-NBS-LRR 
(CNL) proteins characterized by a coiled-coil domain (Meyers et al. 1999; Q. Pan, 
Wendel, and Fluhr 2000; Meyers et al. 2003). There are approximately 150 NBS-LRR- 
encoding genes in Arabidopsis thaliana, over 300 in soybean and over 600 in rice 
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(Meyers et al. 2003; Kang et al. 2012; Shang et al. 2009). Huge differences exist among 
species in terms of the numbers and organization of different NBS-LRR subfamilies, with 
family-specific amplification occurring in legumes and Solanaceae (which includes 
tomato and potato) (Cannon et al. 2002; Plocik, Layden, and Kesseli 2004). Within the 
genome, NBS-LRR genes are organized either as isolated genes or, more frequently, as 
linked clusters of varying sizes that are thought to arise through both tandem and 
segmental duplications and could facilitate rapid R-gene evolution (Meyers et al. 2003; 
Monosi et al. 2004; Richly, Kurth, and Leister 2002; Leister 2004; Ameline-Torregrosa et 
al. 2008; Hulbert et al. 2001). While local tandem duplications are the main contributor to 
tightly linked tandem NBS-LRR clusters, a variety of events are thought to give rise to 
mixed NBS-LRR clusters that contain members from different subfamilies: ectopic 
duplication, transposition, as well as large-scale segmental duplication followed by 
subsequent local rearrangement (Meyers et al. 2003; Baumgarten et al. 2003; Kuang et al. 
2004; McDowell and Simon 2006). The rate of evolution of NBS-LRR genes can be 
rapid or slow, with gene conversion events being frequent in some clades but rare in 
others (Kuang et al. 2004). This heterogeneous rate of evolution is consistent with a birth-
and- death model of R gene evolution, in which gene duplication and unequal crossing-
over can be followed by density-dependent purifying selection (McHale et al. 2006). As 
such, the uneven and clustered distributions of NBS-LRR genes and different selection 
pressures they experience have contributed to the generation of novel resistance 
specificities and to the expansion of this gene family through the mechanisms listed 
earlier (Marone et al. 2013). 
Cysteine-rich peptides (CRP) are extremely abundant in plants, and are divided into 
many classes (M. a Graham et al. 2004; Silverstein et al. 2005; Silverstein et al. 2007). 
While different CRP groups differ in the configuration of conserved cysteine residues in 
the mature peptide, members within each group typically have striking similarities in 
their sequences, expression pattern and function (Broekaert et al. 1997; García-Olmedo et 
al. 1998). While classical CRP groups have active defense functions such as 
antimicrobial activity through the disruption of the pathogen’s membrane (Shai 2002; 
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Thevissen et al. 2003), some CRP groups have passive defense functions that deter 
predation through allergenicity (Himly et al. 2003) and trypsin inhibition (Melo et al. 
2002). In addition to defense roles, various CRP groups seem to be employed in flowers 
and seeds to play reproductive regulatory roles, such as the stigma-specific STIG1 family 
(Goldman, Goldberg, and Mariani 1994), the defensin-like S-locus cysteine-rich (SCR) 
proteins (Schopfer, Nasrallah, and Nasrallah 1999) and the pollen tube attraction 
polypeptides (LUREs) (Okuda et al. 2009). Other CRP groups have evolved functions to 
regulate plant growth and development, such as the rapid alkanization factor (RALF) 
proteins (G. Pearce et al. 2001) and lipid transfer protein (LTP)-like xylogens (Motose, 
Sugiyama, and Fukuda 2004).  
During the last two decades, a large diverse family of CRPs was identified in the 
nodules of M. truncatula showing exclusive nodule-specific expression and a wide range 
of spatio-temporal patterns in the infected cells throughout nodule organogenesis 
(Fedorova et al. 2002; Mergaert et al. 2003; M. a Graham et al. 2004; Mergaert et al. 
2006). To date, these nodule-specific cysteine-rich proteins (NCRs) have been found only 
in legumes belonging to the inverted repeat-lacking clade (IRLC) within the subfamily 
Papilionoideae, and absent from other non-IRLC legumes within the same subfamily, 
such as L. japonicas and G. max (M. a Graham et al. 2004; Alunni et al. 2007). 
Interestingly, in M. truncatula and other IRLC legumes, indeterminate nodules are 
formed where rhizobia undergo terminal differentiation into enlarged bacteroids and lose 
their ability to grow and divide, whereas L. japonicas and G. max form determinate 
nodules in which rhizobia retain the cell size, genome content and viability as free-living 
bacteria (Mergaert et al. 2006). Recent findings showing that NCR peptides act as 
symbiotic plant effectors to direct bacteroid differentiation have led to the speculation 
that NCRs are actually cysteine-rich antimicrobial peptides recruited by IRLC legumes in 
the context of symbiosis to dominate the endo-symbionts (Van de Velde et al. 2010; 
Farkas et al. 2014).  
Previous work based on an earlier version of the Medicago genome (Mt1.0) 
identified 333 NBS-LRRs, including 177 CNLs and 156 TNLs (Ameline-Torregrosa et 
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al. 2008). Likewise, studies using EST sequences from public databases have led to the 
discovery of more than 300 NCR family members in M. truncatula (Fedorova et al. 2002; 
Mergaert et al. 2003; M. a Graham et al. 2004). The observation that clusters of these 
large gene families are frequently found in complex (e.g., assembly gaps that are difficult 
to fill) and repeat-rich regions indicated that they play structurally important role in the 
overall genome architecture (Ameline-Torregrosa et al. 2008). Recently, a high quality, 
BAC-based sequence of the Medicago A17 genome has become available as the 
“reference genome” for the Medicago research community (Tang et al. 2014). This 
reference genome assembly (version 4.0) covers ~80% of the overall genome (estimated 
at 465 Mbp) while capturing ~93% of all predicted gene models (Bennett and Leitch 
2011; Tang et al. 2014). Based on the reference, I was able to compile a much more 
complete set of 860 NBS-LRRs and 717 NCRs using a profile-based approach (Chapter 
1), and characterize their genomic distribution and phylogenetic pattern in this work. 
The availability of a reference genome also enables population studies using next 
generation approaches, allowing for genome-scale analyses of nucleotide diversity and 
inferences on the underlying evolutionary forces shaping gene family diversity (Begun et 
al. 2007; Clark et al. 2007; McNally et al. 2009; Gore et al. 2009). In the case of NBS-
LRR and NCR family, high levels of nucleotide and expression variation among different 
Medicago accessions have already been documented by EST, microarray and 
resequencing efforts (Tesfaye et al. 2013; Branca et al. 2011; Nallu et al. 2014; Stanton-
Geddes et al. 2013). However, due to their large family size, high level of nucleotide 
diversity and frequent structural and copy number variation, characterizing these gene 
families at a genome and population scale has generally turned out to be difficult or even 
unsuccessful. 
Traditional resequencing studies have relied on mapping short reads to a reference 
sequence in order to call polymorphic sites. This introduces a potential bias due to 
significant structural differences between diverse Medicago accessions. Alignment to a 
single reference is most problematic when reads from a divergent Medicago accession, 
such as the functionally important R108, are incorrectly aligned to the A17 reference due 
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to mis-alignment of paralogous regions. With a high within-species nucleotide diversity 
(genome-wide estimates of θw = 0.0063 approximately three times more than found in 
soybean θw-cultivated = 0.0017 bp−1 and θw-wild = 0.0023 bp−1 populations), it may not be 
surprising that only a portion of the (reference) genomic regions can be confidently 
probed with read-mapping approaches. Diversity estimates may thus be underestimated 
due to the elimination of divergent (un-aligned) sequences. In addition, the length 
limitation of short read technologies such as Illumina leads to ambiguous mappings in 
repetitive and duplicated regions. Finally, the incompleteness of the reference genome 
limits our ability to detect variation in regions not present in the reference (e.g., assembly 
gaps) and leads to false alignments and SNP calls if reads from these regions are aligned 
to their next best match. Taken together, duplications that are present in some accessions 
but absent from others, high sequence similarity between recently duplicated family 
members, as well as high divergence between members among accessions (e.g., rapid 
structural changes in NBS-LRRs that often lead to very low sequence similarity between 
ortholog pairs) have seriously limited our understanding of the diversity and evolution of 
important large gene families such as NBS-LRRs and NCRs. 
The distribution of structural variation (SVs) in the Medicago and their impacts on 
important gene families remain largely unknown. Yet this knowledge is essential in 
gaining insight into the genetic basis of legume-rhizobium symbiosis and identifying 
genes underlying phenotypic variation. The only practical way to understand the genomic 
diversity of Medicago fully and to capture the numerous members of such divergent gene 
families is to carry out whole genome sequencing and de novo assembly. Recent 
advances in NGS chemistry and computational approaches in sequence assembly have 
significantly improved the power and reliability of de novo assembly of NGS data. In this 
study, I worked with colleagues to develop de novo genome assemblies of 15 
strategically chosen Medicago accessions. We constructed a Medicago Pan-16 genome 
and proteome, and fully characterized the genomic content and gene family repositories 
for these accessions. Based on these genome assemblies, I was able to systematically 
characterize all types of variation affecting different gene families: single-nucleotide 
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polymorphisms (SNPs), short insertion and deletions (indels) as well as large SVs that 
were not readily detectable by previous read-mapping approaches. I found that although 
SVs are commonly observed in rapidly-evolving large gene families, the way they impact 
family members differs: longer genes are affected by all types of SVs, while shorter 
genes seem to be predominantly affected by copy number changes through tandem or 
segmental duplication. This work illustrates the value of multiple de novo assemblies in 
building and characterizing plant pan-genomes and provides insights in understanding the 
evolution of large gene families underlying important traits. 
Methods 
Sequencing, assembly and functional annotation 
Fifteen M. truncatula accessions from geographically distinct populations (Figure 
2.1) spanning the entire Medicago species range were chosen for deep sequencing and de 
novo assembly. Sequencing was performed using Illumina HiSeq 2000 instruments. For 
each of the fifteen accessions, we made and sequenced one Short Insert Paired End 
library (SIPE) and either one or two Long Insert Paired End (LIPE) libraries following 
the recommendations of the ALLPATHS-LG whole genome assembler (Gnerre et al. 
2011). Each accession was sequenced to an average of 120 fold coverage (Appendix 
Table 2.1) and assembled using the ALLPATHS-LG assembler algorithm (version 
49962) (Gnerre et al. 2011). Assembled genome sizes ranged from 388 Mbp to 428 Mbp, 
values comparable to the reference HM101 genome. Approximately 80%-94% of each 
genome were assembled into scaffolds at least 100 kbp long, with scaffold N50 sizes 
ranging from 268 kbp to 1,653 kbp, and contig N50 sizes around 20 kbp (Table 2.1).  
AUGUSTUS (Stanke2003) was used to make ab initio gene predictions for each 
genome assembly with both RNA-Seq expression evidence and HM101 homology 
evidence. Predicted protein sequences were scanned for PFAM domains (Pfam-A.hmm) 
(Finn et al. 2014) using HMMER (Sean R. Eddy 2011) and processed using custom 
scripts. Domain categories were then assigned to each protein sequence according to the 
most significant Pfam hits. Among the resulting Pfam domains we curated 133 as being 
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associated with transposable elements and grouped these into a large “TE" category. 
NBS-LRR genes were curated using sub-family HMMs (13 TNL subgroups and 22 CNL 
subgroups) built based on previous literature (Ameline-Torregrosa et al. 2008). We also 
ran SPADA (Small Peptide Alignment Discovery Algorithm) (Chapter 1) (Zhou et al. 
2013) with default parameter on each assembly to refine annotation of 516 CRP gene 
subfamilies. 
PacBio long reads was generated to validate the identified structural variation in 
three accessions including HM034, HM056 and HM340. Sequencing was done using 
P4C2 chemistry and Smrtanalysis version 2.1 or P5C3 chemistry and Smrtanalysis 
version 2.3. Reads were filtered at minimum quality of 75, minimum sub-read length of 
50 bp and minimum read length of 50 bp. Final coverage for each accession was 
estimated to be 18-20 fold. 
Comparative analysis and variant detection 
Each de novo assembly was aligned to the Medicago HM101 reference sequence 
(version 4.0) using BLAT (Kent 2002). The resulting alignments were merged, fixed and 
cleaned using custom scripts. BLAT Chain/Net tools were used to obtain a single 
coverage best alignment net in the target genome (HM101), as well as a reciprocal-best 
alignment net between the two genomes. Genome-wide synteny blocks were then built 
for each de novo assembly (against HM101), enabling downstream analyses including 
variant calling, novel sequence identification and ortholog detection. Based on the 
synteny blocks built, I identified SNPs (single base mismatches), short insertions and 
deletions (alignment gaps ≤ 50 bases), as well as different types of structural variants 
(SVs). We were able to accurately detect and characterize large deletions, insertions, 
translocations and copy number gain and loss events at base pair resolution. Variant calls 
from 15 accessions were merged to a single VCF file using Bcftools (H. Li et al. 2009), 
with missing genotypes deducted where possible using synteny alignment information. 
We then partitioned the genome into 100-kbp sliding windows and calculated gene 
  82 
density, TE density, NBS-LRR and CRP density, as well as nucleotide diversity (θπ) 
estimates for SNPs, short InDels and SVs in each window. 
Construction of a Medicago Pan-16 Proteome 
For each de novo assembly, I first identified synteny orthologs (to HM101) using 
gene annotations from both genomes. For example, an ortholog pair can be determined if 
one gene in HM101 can be aligned to an HM004 gene through synteny at ≥80% sequence 
similarity and ≥70% sequence coverage. I also incorporated structural variant information 
(i.e., large insertions and deletions) in calling gene gains and losses as well as their 
locations. By repeating this for all 15 de novo sequenced accessions, I obtained a raw 
ortholog matrix with 16 columns representing 16 genomes and 70,000+ rows each 
representing an ortholog group. However, a gene gain event (insertion relatively to 
HM101) occurring in more than two accessions tended to independently introduce 
multiple row entries while actually representing a single event. I thus identified all unique 
insertion loci and did multiple sequence alignment of all inserted genes in each locus. 
Inserted genes were then clustered based on sequence similarity using MCL (Enright, 
Dongen, and Ouzounis 2002) and assigned to different ortholog groups. Since synteny 
blocks do not necessarily cover 100% of the reference gene space, there are numerous 
cells in the ortholog matrix with missing data, meaning that the ortholog status in those 
accessions cannot be determined through synteny. On the other hand, I noticed a 
considerable fraction of genes (10-20%) in one or more de novo assemblies residing on 
un-anchored (and short) scaffolds that are not in synteny with the reference genome. With 
the belief that some of the missing orthologs are actually among these orphan genes, I 
used a Reciprocal Best Hit (RBH) approach to assign orthologous relationships for genes 
without syntenic orthologs, and updated the ortholog matrix. Finally, for genes that could 
not be assigned to an ortholog group using either the synteny or RBH approach, I did an 
all-against-all Blast search and ran orthoMCL (L. Li, Stoeckert, and Roos 2003) and 
various custom scripts to generate ortholog groups. Large ortholog groups were 
partitioned so that each group has no more than one member from each accession. This 
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resulted in a Pan-16 proteome matrix where each ortholog group has between one 
(accession-specific) and 16 (shared by all accessions) members. The status in each cell 
can be “synteny-ortholog”, “RBH-ortholog”, “deleted”, “deleted-but-has-RBH-ortholog” 
or “missing data”. Each ortholog group was classified by the most frequent PFAM 
categories assigned to group members. Within each ortholog group, I built a multiple 
sequence alignment and calculated protein sequence distance matrix, from which the 
mean pairwise protein distance is obtained. 
Gene family analysis 
SNP-based nucleotide diversity were then estimated for the coding regions of each 
gene, and the distribution of (θπ) for different gene families was obtained. Based on the 
Pan-16 proteome matrix, I generated an allele frequency spectrum (AFS) for each gene 
family using presence / absence information from each ortholog group. For each gene 
family, I also obtained the distribution of mean protein pairwise distance for each gene 
family by making a multiple sequence alignment and building a protein distance matrix. 
For selected gene families including CRPs and NBS-LRRs, I then built a score matrix 
with 16 accessions as rows and all family members as columns. Each cell in the matrix 
ranges from 0 (deleted) to 1 (present) representing the mean protein sequence similarity 
with orthologs from other accessions. Finally, I performed hierarchical clustering on the 
rows of the matrix and generated a dendrogram similar to the SNP-based phylogeny of 16 
Medicago accessions. 
Identification of gene family expansion / contraction events and validation using 
PacBio sequence 
A list of gene gain (family expansion) and loss (family contraction) events were 
directly inferred from the Pan-16 proteome matrix. I characterized these events within 
different gene families with a special focus on the NBS-LRR and CRP gene families. For 
both gene gain and loss events PacBio long read sequences for three accessions (HM034, 
HM056 and HM340) were included to provide additional support. In the case of gene 
gains, my analysis specifically looked for tandem duplication events where there is an 
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identifiable ancestral gene (with >90% sequence similarity) in the vicinity (15 kbp) of the 
new gene, followed by scanning PacBio read alignments that span both the ancestral and 
newborn (novel) genes to provide support for the predicted duplication. For each gene 
gain and loss event, I also ran CLUSTALO (Sievers et al. 2011) to build a multiple 
sequence alignment, thereby obtaining a phylogeny to visualize any predicted changes in 
gene tree topology. 
Results 
Genome-wide identification of NBS-LRR and CRP gene families 
I comprehensively scanned the Medicago reference genome (Mt4.0) for NBS-LRRs 
and CRPs using a combined approach (see Methods). A total of 860 NBS-LRRs and 
1,428 CRPs (including 717 NCRs) were identified, annotated and assigned to a 
subfamily. Both gene families showed uneven and clustered distribution in the genome 
(Figure 3.1, 3.2). NBS-LRRs are mostly located on chromosomes 3 and 6, with members 
on the two chromosomes together accounting for 44% of the entire family. CRPs, on the 
other hand, are mostly clustered on chromosomes 2, 7 and 8, with several big clusters 
containing 15-20 tandem copies of a single subfamily on these chromosomes. Tandem 
duplication seems to be the primary mechanism driving the local expansion of many 
subfamilies (e.g., TNL0600 subfamily at the start of chromosome 6). Using a sliding 
window size of 100 kb, more than 80% of all NBS-LRRs reside in clusters of two or 
more, and more than 60% in clusters of five or more. Segmental duplication, on the other 
hand, also contributes to the large-scale expansion of several subfamilies, such as the 
CNL1600 clusters on chromosomes 5 and 8. I also noticed occasional ectopic duplication 
events, resulting in the transposition of foreign subfamily members to existing clusters 
(e.g., integration of a TNL0800 gene to a CNL0600 cluster on chromosome 5). These 
observations are consistent with a birth and death model in which tandem and segmental 
duplications are followed by density-dependent purifying selection (McHale et al. 2006). 
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Functional annotation of 15 Medicago accessions 
In order to understand the natural variation affecting different gene families at a 
population level, my colleagues and I sequenced, assembled and annotated 15 additional 
M. truncatula accessions. We integrated homology evidence, RNA-Seq expression, and 
ab initio prediction results in the annotation process. The number of transposable element 
(TE)-related genes identified in the 15 de novo assemblies were on average 20% lower 
than the HM101 reference – an indication that the de novo assemblies have missed or 
collapsed some repetitive sequences. Total number of non-TE genes (52,000 to 56,000), 
however, is almost comparable to the reference (55,000, Table 3.1). Median protein 
length for non-TE genes ranged from 218 to 228 amino acids – nearly equal to the 
estimate of 228 amino acids in HM101, an indication that long scaffold and contig N50s 
have helped to maintain the intactness of gene models. The quality of the annotation was 
supported by the observation that 77-87% of all predicted genes (including TEs) were 
either supported by an HM101 homolog or by expression evidence (as determined by 
RNA-Seq) (Table 2.2). Large gene families such as NBS-LRRs and CRPs generally have 
consistent numbers of members among accessions (Table 2.2, Appendix Table 2.1. 
However, these gene families harbored complicated homology relationships with the 
accessions differing markedly in the size of specific sub-families (Appendix Table 2.5, 
2.6). Further analysis suggests family-specific expansion / contraction is a frequent 
phenomenon observed in large gene families (see Discussion). 
Population genetics analysis 
I characterized the variability of different gene families using SNP-based nucleotide 
diversity (θπ) in coding regions. Not surprisingly, the two broad categories of NBS-LRRs 
and TEs show the highest nucleotide diversity (Figure 3.3A). NCRs and other defensin-
like genes (DEFLs, CRP0000-CRP1030) also harbor higher-than-average levels of 
diversity (Figure 3.3A). Other dynamic gene families such as FAR1, Exo_endo_phos, F-
box and HSP70 are also among the most variable. I also characterized the effect of 
sequence variation with a focus on SNPs causing significant changes to the encoding 
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product (i.e., large-effect SNPs). While approximately 20% of all non-TE genes are 
affected by at least one large-effect SNP (in 12 “ingroup” accessions), as much as 70-
80% of TEs and NBS-LRRs have reading frame changes (Figure 3.3B). The proportion 
of family members with reading frame changes basically follows the same trend as 
nucleotide diversity levels in different gene families, with the notable exception of CRP 
families (NCR, CRP0000-1030, CRP1600-6250), where only 10% are affected by large-
effect SNPs, potentially as a result of the small size of these families (typically just 20-50 
amino acids). 
Novel coding sequences absent in the HM101 reference 
When comparing each de novo assembly to the reference HM101 genome (Mt4.0), I 
found extensive “novel” sequence that could not be aligned to the reference even using a 
relaxed alignment parameter (70%-80% sequence percent identity). Among the novel 
sequences identified, 1.3 - 2.5 Mbp per accession were predicted to be protein coding 
(see Chapter 2 for detail). Enriched in these novel coding genes are TE-related genes and 
NBS-LRRs. While on average only 2% of coding non-TE genes were identified as absent 
from the reference accession, as many as 6% of NBS-LRRs contribute to the “novel” 
gene pool (Figure 3.4). NCRs, unlike other groups in the broader CRP family including 
classic DEFLs (CRP000-1030) and CRP1600-6250, contribute a significant amount 
(3.4%) to the novel gene pool. Considering the recently employed role of NCRs in 
directing endo-symbionts, it is possible that this large family is still undergoing a rapidly 
expanding and innovating process that leads to novel specificity in legume-rhizobia 
interaction. 
Proteome diversity 
To understand the effect of sequence variants on proteins, it is insufficient to study 
isolated DNA polymorphisms in the context of the reference annotation - especially at 
such high level of divergence (SNP density from 0.63% to 2.67%). Therefore, we fully 
annotated the 15 de novo assemblies and systematically identified ortholog groups among 
accessions, creating a pan-16 proteome. In addition to the 68k reference gene models, we 
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identified 78k ortholog groups with no HM101 members. Within this total of 146k 
groups, 31k ortholog groups were shared among all 16 accessions, and 94k were shared 
by at least two accessions (Figure 3.5A). A total of 52k singletons were also identified 
including as little as 2.3k HM004-specific to as much as 8.1k HM340-specific genes. The 
size curve of the pan-16 proteome resembles the pan-genome curve, with a stable core 
proteome (31k) plus a much larger dispensable proteome that still sees significant 
increase after inclusion of 15 Medicago accessions (Figure 3.5B). 
We further investigated protein diversity in different gene families based on 
alignments of each ortholog group. On average, the distance of any two randomly 
selected protein orthologs was 1.8% (i.e., mean pairwise protein distance, Figure 3.6). 
However, the two groups of NBS-LRRs and TEs are extremely divergent, with 
approximately 10% difference between each ortholog pair. Other dynamic gene families 
such as FAR1, HSP70 and F-box, also show high levels of protein diversity. 
Interestingly, the NCR gene family did not show above-normal protein diversity level in 
contrast to its increased nucleotide diversity estimate (Figure 3.3, 3.6). This could be due 
to these reasons: 1) synonymous SNPs are prevalent in NCRs but do not contribute to 
diversity at the protein level; 2) gene structure predictions made on short-read-only de 
novo assemblies may sometimes be inaccurate due to sequencing and assembly errors, 
thus differentially inflating the protein distance estimates for larger genes based on 
protein sequence alignments; however, this is less an issue for smaller one- and two-exon 
genes such as NCRs. We speculate that point #2 may be more likely since there is no 
reason to see the protein diversity for non-TE coding genes going up beyond the level of 
F-box family.  
Characterization of NBS-LRR gene family variation 
The NBS-LRR gene family members are known for their high variability and rapid 
evolving nature. In addition to the highest point mutation rate and largest proportion of 
reading-frame changes (Figure 3.3), I also observed various types of structural changes 
targeting NBS-LRRs through mechanisms including gene truncation, domain swapping 
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and gene fusion (Figure 3.8). Indeed, among all gene families, NBS-LRRs contribute the 
most to the novel gene pool in the population (Figure 3.4), and harbors the highest level 
of protein diversity (Figure 3.5). Using the sequence identities of all NBS-LRRs in 16 
Medicago accessions, I was able to reconstruct the original Medicago phylogeny through 
hierarchical clustering (Figure 3.9), an indication that in general, the gene tree of NBS-
LRRs followed the evolutionary trajectory of different accessions within the population. 
However, subfamilies of NBS-LRRs are frequently affected by insertions, deletions and 
copy number changes (Figure 3.10). In particular, I noticed that NBS-LRR gene families 
contain large numbers of accession-specific genes (Figure 3.10), consistent with the 
highest proportion of novel genes among all gene families (Figure 3.4). It is possible that 
most of these accession-specific genes are actually members of existing ortholog groups 
that have accumulated too many point mutations – as evidenced by the highest nucleotide 
diversity – to be placed in existing groups. In other words, these gene families are 
evolving much faster than other conserved gene families as a response to the ever-
changing pathogen environment. 
Characterization of NCR gene family variation 
As a rapidly expanding gene family in the Medicago species (Fedorova et al. 2002; 
Mergaert et al. 2003). the NCR family also shows evidence of high nucleotide diversity 
and high novel sequence content (Figure 3.3, 3.4). Similar to NBS-LRRs, hierarchical 
clustering of the protein sequence score matrix for CRPs also resulted in a tree 
resembling the Medicago phylogeny (Figure 3.11). In contrast to NBS-LRRs, the CRP 
genes are much shorter - typically in the range of 300 - 1000 bp (Silverstein et al. 2007). 
Presumably as result of being smaller targets, CRPs are less frequently affected by large 
SVs involving mechanisms such as gene truncation or domain swapping. Instead, 
removals, insertions or duplications of a complete CRP gene are more frequently 
observed, resulting in contraction or expansion of a certain sub-family clade (Figure 3.12 
and 3.13). For example, out of the total of 274 CRP insertion / copy number gain events 
in HM340, I identified 74 cases of tandem duplications where the duplicated CRP has a 
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highly similar ancestor (>90%) in the vicinity (within 15 kbp). Using long PacBio 
sequence reads available for HM340, I was able to validate 57 (77%) of these tandem 
duplication events (See Figure 3.14 for illustration). 
Discussion 
Family-specific expansion / contraction is prevalent in large gene families 
Typical gene families generally have consistent numbers of members across different 
accessions, with occasional insertion/deletion or translocation events (Figure 3.15). 
Orthologous relationships are simple and straightforward in these conserved gene 
families. However, large gene families such as NBS-LRRs and CRPs show very different 
scenario. While subfamilies generally have consistent numbers of members among 
accessions (Figure 3.10 and 3.13, Appendix Table 2.3), the orthologous relationships, 
especially for the NCR subfamilies, are much more complex with frequent indels, 
translocations and CNVs affecting family members (Figure 3.13). Different subfamilies 
also seem to have different evolutionary history (Figure 3.13). In addition, NBS-LRRs 
show considerable presence/absence variation among different accessions (Figure 3.9 and 
3.10). As a result of high point mutation rates (i.e., highest nucleotide diversity), synteny-
based orthologous relationships are rare for NBS-LRR subfamilies (Figure 3.10). Many 
family members exist as accession-specific singletons with no detectable orthologs (or 
too divergent to be detected) in other accessions – partly explaining their highest 
contribution to the novel gene pool of the population. 
De novo assemblies capture “novel” gene pool in the population 
Based on the novel sequences we identified in the 15 de novo assembly, we found 
that large gene families including NBS-LRRs, NCRs, TEs, HSP70, are the major 
contributors the “novel” gene pool in the Medicago population (Figure 3.4). Interestingly, 
these gene families were also found among the most poorly characterized genomic 
regions (see Figure 2.4 and Chapter 2 for detail). In fact, based on the synteny alignments 
built for each de novo assembly we were able to cover 75% (31,048) of all non-TE 
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reference gene models (≥ 80% coding regions in ≥ 10 accessions). By contrast, only 44% 
(5,418) TEs and 48% (414) NBS-LRRs were covered using the same criteria. Enrichment 
of these complex gene families in this novel gene pool partially explains their poor 
coverage by synteny alignment. The rapid evolving nature and turnover of these genes 
greatly accelerate their divergence within population, thus preventing both read mapping 
and syntenic anchoring. That said, the total number of NBS-LRRs predicted in each de 
novo assembly did not differ significantly from the reference annotation (Table 3.1), 
indicating that instead of being missed by our assemblies, these NBS-LRRs most likely 
were captured and assembled to relatively short and isolated contigs that could not be 
anchored to reference chromosomes (confirmed in Figure 3.10). 
Different evolution patterns of NBS-LRRs and NCRs 
The NBS-LRR gene family is known for its high variability and rapid evolving 
nature. In addition to the highest point mutation rate and largest proportion of reading-
frame changes (Figure 3.3), NBS-LRRs are also the major contributor to novel gene pool 
in the population (Figure 3.4), and harbor the highest level of protein diversity (Figure 
3.6 and 3.9). In fact, it is frequently found that NBS-LRR genes have multiple allelic 
forms in the population that are dramatically different (see Appendix Figure 3.1 for 
illustration). Protein ortholog analysis also reveals NBS-LRRs are frequently affected by 
PAVs (Figure 3.9 and 3.10). These PAVs exist as accession-specific singletons with no 
detectable orthologs (or too divergent to be detected) in other accessions, a result of the 
family’s much higher point mutation rate. NCRs, on the other hand, shows a relatively 
different evolution pattern. While the NCR gene family is also notable for a high level of 
nucleotide diversity and significant contribution to the novel gene pool, it is less 
frequently affected by structural variation, probably due to the small size of the gene 
body (Figure 3.12). As a result, the actual protein diversity level is not particularly high 
for NCRs (Figure 3.6). Nevertheless, protein ortholog analysis revealed frequent gene 
gain and loss events for NCR subfamilies (Figure 3.13), suggesting the primary 
innovation for NCRs are subfamily expansion and contraction through tandem 
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duplication and deletion events followed by diversifying selection. Indeed, we detected 
and characterized the copy number changing events in the NCR subfamilies and validated 
the tandem duplication events with PacBio long reads (Figure 3.14). The exact 
mechanism how the NCR subfamilies expand and translocate still requires further 
investigation. 
Conclusion 
In this study we constructed high quality de novo assemblies and systematically 
characterized natural variation in 15 M. truncatula accessions. We built a Medicago Pan-
16 genome and proteome, and fully characterized all types of variation affecting different 
gene families: single-nucleotide polymorphisms (SNPs), short insertion and deletions 
(indels) as well as large SVs that were not detectable by previous read-mapping 
approaches. We confirmed the long established view that the NBS-LRR gene family is by 
far the most variable and dynamic family, contributing significantly to population novel 
gene pool and playing a structural role in genome architecture and stability. We also 
found that unlike traditional DEFLs and CRPs, the NCR gene family shows higher levels 
of diversity and is frequently affected by gene gain and loss events. This work illustrates 
the value of multiple de novo assemblies in building and characterizing plant pan-
genomes and provides insights in understanding the evolution of large gene families 
underlying important traits. 
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Table 3.1. Functional annotation statistics. 
 # Total 
Genes 
TE non-TE NBS-
LRR 
CRP Median Prot. 
Len.* 
RNA-seq 
(%)# 
Homology 
(%)& 
RNA-seq + 
Homology (%) 
HM101 67102 12312 54790 860 1428 228 39.6 - 39.6 
HM058 64146 9540 54606 800 1280 222 - 85.2 85.2 
HM056 65691 10379 55312 811 1304 220 36.4 84.9 86.9 
HM125 67346 11175 56171 781 1280 218 - 84.4 84.4 
HM129 65607 10455 55152 818 1278 222 - 83.6 83.6 
HM034 64612 9958 54654 774 1266 222 36.0 83.1 85.2 
HM095 65524 10197 55327 823 1283 222 - 82.8 82.8 
HM060 64648 9967 54681 799 1272 223 - 83.7 83.7 
HM185 65921 10666 55255 822 1274 222 - 83.4 83.4 
HM004 64374 9680 54694 797 1278 224 - 82.8 82.8 
HM050 65691 10282 55409 828 1289 224 - 82.6 82.6 
HM023 64310 9661 54649 797 1281 222 - 83.2 83.2 
HM010 65373 10339 55034 834 1304 223 - 83.2 83.2 
HM022 59882 8193 51689 704 1295 227 - 78.6 78.6 
HM340 64587 9387 55200 784 1287 228 36.1 75.1 77.6 
HM324 60236 7751 52485 747 1213 221 - 76.6 76.6 
*Median protein length (number of amino acids) was estimated using non-TE coding genes; 
#RNA-Seq was done for four accessions using both un-inoculated root tissue and nodule; number indicates percentage of total predicted transcripts 
with FPKM > 0; 
&Number indicates percentage of total predicted transcripts with at least one Mt4.0 ortholog (either syntenic ortholog or RBH-based homolog). 
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Figure 3.1. Genome distribution of NBS-LRR gene family in HM101 reference genome.  
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Figure 3.2. Genome distribution of CRP gene family in HM101 reference genome.  
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Figure 3.3. SNP-based nucleotide diversity estimates of different gene families (A) and proportion members affected 
by different types of large-effect SNPs (B). 
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Figure 3.4. Proportion of novel genes identified in different gene families. 
“Novel genes” are gene family members where 50% of the coding sequence regions are not present in the reference HM101 accession 
(i.e., cannot align anywhere in the reference genome). Error bars indicate 25%, 50% and 75% quantiles of the proportion distribution 
in 15 accessions. 
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Figure 3.5. Allele frequency spectrum of ortholog groups identified in all 16 M. truncatula accessions (A) and the 
Pan-16 proteome size curve (B). 
The pan-proteome size curve and core-proteome size curve were derived by adding one accession to the pool at a time and counting the number of 
shared ortholog groups (including members in all accessions, i.e., core-proteome, ‘x’ in the figure) and the total number of ortholog groups (pan-
proteome, ‘o’ in the figure). This process was repeated 8 times by shuffling the order of accessions.  
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Figure 3.6. Distribution of mean pairwise protein distances in different gene 
families. 
Barplot represents first quantile, median and third quantile of the distribution of mean 
pairwise protein distances. 
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Figure 3.8. Illustration of NBS-LRR genes affected by different types of 
structural variants. 
(A) Insertion in the first exon results in intron-exon structure change in the gene body in 
the HM340 ortholog (relatively to HM101); (B) a number of insertions and deletions 
result in truncation of the first half and fusion of the second half with a downstream gene 
in HM185; (C) synteny between HM034 and HM101 breaks at a NBS-LRR gene 
resulting in insertion / deletion / domain swapping / domain fusion of the ortholog pair.  
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Figure 3.9. The NBS-LRR sequence identity matrix and hierarchical clustering. 
Each cell in the score matrix ranges from 0 (gene deleted) to 1 (gene identical) representing the mean protein sequence similarity with 
orthologs from other accessions. Hierarchical clustering was performed on the rows of the matrix to generate a dendrogram similar to 
the Medicago phylogeny. 
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Figure 3.10. Ortholog status of selected NBS-LRR subfamilies: (A) TNL0850, 
(B) TNL0480 and (C) CNL0950. 
“Syntenic ortholog”: ortholog status can be determined by synteny alignment (with 
HM101); “RBH ortholog”: no synteny ortholog can be found but reciprocal BLAST 
search identifies an ortholog (typically on short, separate scaffolds); “translocated”: 
synteny ortholog is removed from original location and found in another location; 
“deleted”: synteny ortholog is deleted from original location and not present elsewhere in 
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the de novo assembly; “NA”: insufficient information (synteny coverage, BLAST search) 
to infer the ortholog status at this locus. 
Green lines at the bottom give their chromosomal locations with “chrU” standing for 
unanchored A17 (HM101) short contigs and “chrZ” standing for ortholog groups with no 
A17 members (i.e., not present in HM101). Purple lines on top indicate locations of gene 
clusters (within 15 kbp downstream or upstream to the next). 
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Figure 3.11. The CRP sequence identity matrix and hierarchical clustering. 
Each cell in the score matrix ranges from 0 (gene deleted) to 1 (gene identical) representing the mean protein sequence similarity with 
orthologs from other accessions. Hierarchical clustering was performed on the rows of the matrix to generate a dendrogram similar to 
the Medicago phylogeny. 
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Figure 3.12. Illustration of NCR genes affected by different types of 
structural variants. 
(A) Deletion of the signal peptide of an NCR gene leads to loss-of-function of the 
HM185 ortholog; (B) Deletion of two NCRs results in a cluster size change from 4 copies 
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in HM101 to 2 copies in HM034 (or more likely, a tandem duplication in HM101 relative 
to HM034); (C) Inversion of gene cluster containing 5 NCRs in HM034; (D) Tandem 
duplication of at least 17 copies of an NCR cluster in HM023. 
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Figure 3.13. Ortholog status of selected CRP subfamilies: (A) CRP0110 
(mycorhizal-specific defensin), (B) CRP0355 (reproductive-specific DEFL), 
(C) CRP1430 (6-cysteine NCR) and (D) CRP1520 (4-cysteine NCR). 
“Syntenic ortholog”: ortholog status can be determined by synteny alignment (with 
HM101); “RBH ortholog”: no synteny ortholog can be found but reciprocal BLAST 
search identifies an ortholog (typically on short, separate scaffolds); “translocated”: 
synteny ortholog is removed from original location and found in another location; 
“deleted”: synteny ortholog is deleted from original location and not present elsewhere in 
the de novo assembly; “NA”: insufficient information (synteny coverage, BLAST search) 
to infer the ortholog status at this locus. 
Green lines at the bottom give their chromosomal locations with “chrU” standing for 
unanchored A17 (HM101) short contigs and “chrZ” standing for ortholog groups with no 
A17 members (i.e., not present in HM101). Purple lines on top indicate locations of gene 
clusters (within 15 kbp downstream or upstream to the next). 
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Figure 3.14. Tandem duplication of an NBS-LRR together with a CRP is supported long PacBio reads. 
Blue and red segments represent reads in forward and reverse strands. 
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Figure 3.15. Ortholog status of selected (typical) gene families: (A) 
auxin_inducible, (B) deaminase and (C) peroxidase. 
“Syntenic ortholog”: ortholog status can be determined by synteny alignment (with 
HM101); “RBH ortholog”: no synteny ortholog can be found but reciprocal BLAST 
search identifies an ortholog (typically on short, separate scaffolds); “translocated”: 
synteny ortholog is removed from original location and found in another location; 
“deleted”: synteny ortholog is deleted from original location and not present elsewhere in 
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the de novo assembly; “NA”: insufficient information (synteny coverage, BLAST search) 
to infer the ortholog status at this locus. 
Green lines at the bottom give their chromosomal locations with “chrU” standing for 
unanchored A17 (HM101) short contigs and “chrZ” standing for ortholog groups with no 
A17 members (i.e., not present in HM101). Purple lines on top indicate locations of gene 
clusters (within 15 kbp downstream or upstream to the next). 
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Appendices 
Appendix Table 1.1. CRPs predicted by SPADA in A. thaliana using E-value 
threshold of 0.001. 
Appendix Table 1.2. CRPs predicted by SPADA in M. truncatula using E-
value threshold of 0.001. 
Appendix Table 1.3. Expression support of the Arabidopsis CRP test set. 
Appendix Table 1.4. Expression support of the Medicago CRP test set. 
Appendix Table 1.5. Expression support of the CRPs predicted by SPADA in 
A. thaliana. 
Appendix Table 1.6. Expression support of the CRPs predicted by SPADA in 
M. truncatula. 
Appendix Table 1.7. CRPs predicted by SPADA in A. thaliana using E-value 
threshold of 1. 
Appendix Table 1.8. CRPs predicted by SPADA in M. truncatula using E-
value threshold of 1. 
Appendix Table 1.9. SPH peptides predicted by SPADA in A. thaliana. 
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Appendix Table 1.10. Evaluation of SPADA, AUSPD and OrysPSSP using the 
manually-curated test set. 
 A. thaliana M. truncatula 
  AUSPD SPADA OrysPSSP SPADA 
Identical* 88 618 83 322 
Minor conflict# 8 49 11 72 
Major conflict$ 43 38 125 71 
Missed^ 610 28 342 61 
*Number of gene models identical with the test set;  
#Number of gene models overlapping with the test set and in the same reading frame;  
$Number of gene models overlapping with the test set but in a different reading frame; 
^Number of gene models in the test set  that were missed by AUSPD/OrysPSSP/SPADA. 
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Appendix Table 2.1. Sequencing statistics of 15 M. truncatula accessions. 
 SIPE 
(Gb) 
LIPE 
(Gb) 
SIPE detail LIPE detail Coverage 
(fold)* 
HM004 25.0 39.2 ~50X KAPA ~45X Original LIPE, 
34X Nextera 
128.5 
HM010 20.4 37.7 ~41X KAPA ~31X Original LIPE, 
~44X Nextera 
116.3 
HM022 24.5 27.9 ~49X KAPA ~50X Nextera 104.9 
HM023 24.2 41.4 ~48X KAPA ~53X Nextera 131.3 
HM034 27.1 32.6 ~54X KAPA ~65X Nextera 119.5 
HM050 20.4 34.2 ~41X KAPA ~27X original LIPE, 
~41X Nextera 
109.2 
HM056 78.6 56.8 ~109X TruSeq v3, 
~49X KAPA 
~51X Nextera; ~33X 
original Illumina 
270.8 
HM058 32.2 35.3 ~64X KAPA ~45X Nextera 135.0 
HM060 24.3 24.1 ~49X KAPA ~47X Nextera  96.9 
HM095 26.6 29.7 ~53X KAPA ~58X Nextera 112.5 
HM125 21.8 24.0 ~44X KAPA ~48X Nextera  91.6 
HM129 24.8 22.2 ~50X KAPA ~44X Nextera  93.9 
HM185 21.2 28.6 ~42X KAPA ~57X Nextera  99.5 
HM324 25.0 41.3 ~50X KAPA ~52X Nextera 132.6 
HM340 33.2 45.3 ~66X TruSeq v3 ~33X original LIPE, 
~58X Nextera LIPE 
157.1 
*Coverage was estimated using an assumed genome size of 500 million bases. 
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Appendix Table 2.2. Member counts of different gene families annotated in 
15 de novo assemblies. 
Appendix Table 2.3. Member counts of CRP subfamilies identified by SPADA 
in 15 de novo assemblies.. 
Appendix Table 2.4. Member counts of NBS-LRR subfamilies in 15 de novo 
assemblies. 
Appendix Table 2.5. Member counts of different TE subfamilies in 15 de novo 
assemblies. 
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Appendix Table 2.6. Correlation of nucleotide diversity estimates (SNPs, 
short Indels and large SVs) with non-TE genes, TEs, NBS-LRRs and CRPs. 
 pi_snp pi_indel pi_sv 
Non-TE genes r = -0.229, p = 6.58e-47 r = -0.212, p = 1.96e-40 r = -0.155, p = 3.27e-22 
TEs r = 0.328, p = 0 r = 0.330, p = 0 r = 0.319, p = 0 
NBS-LRR r = 0.282, p = 0 r = 0.193, p = 0 r = 0.254, p = 0 
CRP r = 0.089, p = 3.02e-08 r = 0.044, p = 0.00653 r = 0.037, p = 0.0223 
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Appendix Figure 1.1. Performance comparison of five gene prediction components under different search E-value 
threshold  
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Appendix Figure 1.2. Genome distribution of CRPs predicted in Arabidopsis thaliana. 
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Appendix Figure 1.3. Genome distribution of CRPs predicted in Medicago truncatula. 
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Appendix Figure 1.4. Multiple sequence alignments of Medicago CRP sub-
families CRP0000 and CRP1400. 
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Appendix Figure 1.5. A typical Arabidopsis CRP mis-annonated in 
Arabidopsis Unannotated Secreted Peptide Database (AUSPD). 
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Appendix Figure 1.6. A typical rice CRP mis-annotated in OrysPSSP. 
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Appendix Figure 1.7. Sub-class alignments of three Arabidopsis NCRs with 
Medicago NCRs. 
In each alignment the first sequence comes from Arabidopsis and the rest all come from 
Medicago. 
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Appendix File 1.1. Manually curated CRPs (test set) in A. thaliana and M. 
truncatula (in GFF3 format). 
 
Appendix File 1.2. CRP predictions made by SPADA in A. thaliana and M. 
truncatula using search E-value threshold of 0.001 (in GFF3 format). 
  
Appendix File 1.3. Novel CRP predictions made by SPADA in A. thaliana and 
M. truncatula as determined by manual inspection (in GFF3 format). 
  
Appendix File 1.4. SPH predictions made by SPADA in Arabidopsis using 
search E-value threshold of 0.001 (in GFF3 format). 
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Appendix Figure 2.1. Minor allele frequency (MAF) spectrum of SNPs in 
different categories.  
Large effect SNPs include lost of start or stop codon, gain of premature stop codon, as 
well as splice donor or acceptor variant. 
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Appendix Figure 2.2. Proportion sequences identified as novel (absent in 
HM101) in different gene families. 
Bars indicate 25%, 50% (median) and 75% quantiles of proportion novel sequence in 12 
ingroup accessions. 
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Appendix Figure 2.3. Size distribution of short InDels (less than 50-bp) called 
by the reference mapping-based approach and synteny-based approach. 
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Appendix Figure 2.4A. Comparison and characterization of SNP calling in 
HM004 from two different approaches. 
(A) Venn-diagram showing overlap of mapping-based SNP call set and assembly-based 
call set; (B) Distribution of mapping-only SNPs in different genomic classes (outer ring) 
and genome-wide distribution of different genomic classes (inner piechart); (C) 
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Distribution of read-depth support for mapping-only SNP calls and overlapping SNP 
calls; (D) Proportion of assembly-only SNP calls binned by different sequence identity 
classes; (E) Proportion of heterozygous and homozygous SNP calls (mapping-based) 
validated by assembly-based approach; (F) Proportion of heterozygous SNP calls (out of 
all mapping-based calls) binned by different sequence identity classes. 
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Appendix Figure 2.4B. Comparison and characterization of SNP calling in 
HM023 from two different approaches. 
(A) Venn-diagram showing overlap of mapping-based SNP call set and assembly-based 
call set; (B) Distribution of mapping-only SNPs in different genomic classes (outer ring) 
and genome-wide distribution of different genomic classes (inner piechart); (C) 
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Distribution of read-depth support for mapping-only SNP calls and overlapping SNP 
calls; (D) Proportion of assembly-only SNP calls binned by different sequence identity 
classes; (E) Proportion of heterozygous and homozygous SNP calls (mapping-based) 
validated by assembly-based approach; (F) Proportion of heterozygous SNP calls (out of 
all mapping-based calls) binned by different sequence identity classes. 
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Figure Link: https://www.dropbox.com/s/oa5glsq4fr3zwjb/figS2.5.pdf?dl=0 
Appendix Figure 2.5. Synteny alignment confirms rearrangement of the long 
arms of chromosomes 4 and 8. 
Four breakpoints (br1 – br4) are indicated by “x”. 
 
 
Figure Link: https://www.dropbox.com/s/cj3wzddi122dzfi/figS2.6.pdf?dl=0 
Appendix Figure 2.6. Closer look at the chromosome 4/8 translocation 
breakpoints. 
 
 
Figure Link: https://www.dropbox.com/s/xrrmij9zv8ujert/figS2.7.pdf?dl=0 
Appendix Figure 2.7. Genome browser screenshots showing genes around the 
breakpoints of chromosome 4/8 rearrangement. 
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Appendix Figure 3.1. Illustration of an NBS-LRR gene with at least 4 allelic 
forms (i.e., haplotypes, including HM101) in the 15 accessions surveyed. 
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